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Breast milk, the gold standard for infant nutrition, could prevent up to 13% of child 
deaths worldwide. However, many mothers are unable to breastfeed due to health conditions and 
other factors. Because of this, a network of more than 500+ human milk banks, which collect and 
distribute donated breast milk to infants, have emerged worldwide. However, operational costs to 
ensure the safety of this milk remain time-intensive and costly.  
There are no existing diagnostics for rapid and on-site detection of bacterial contaminants 
in donated milk. Currently, many milk banks send samples to outside laboratories for bacterial 
culturing tests, which take 24-48 hours to receive results. In contrast, MilkGuard is an on-site 
detection method which ensures results in hours rather than days. To determine whether or not 
E.coli ​is present in donated milk, a drop of milk is deposited onto the sensor. If the milk is 
contaminated, the sensor will turn a blue color due to an enzyme-substrate reaction of the 
bacteria. 
The goal of the project is to create a cost and rapid alternative to traditional bacterial 
culturing testing to screen for ​E. coli​ bacteria in donated human breast milk. This will allow 
users to ensure that milk samples are sterile enough to provide to young infants, while also 
providing breast milk banks an alternative that will allow them to screen more samples in a 
shorter amount of time.  
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CHAPTER 1: INTRODUCTION 
 
1.1 Background Motivation and Big Picture Rationale 
On a global scale, breast milk is considered the gold standard for infant nutrition. 
Containing protective antibodies that optimize an infant’s chances of survival, breast milk is the 
ideal substance to provide the necessary nourishment in the first six months of life.  In addition 1
to offering essential nutrients, breastfeeding provides significant long-term benefits that can 
contribute to positive health outcomes. It can lower the risk for infectious diseases like 
diarrhea-related diseases and respiratory infections, as well as lowering the likelihood of 
developing chronic conditions such as asthma and allergies in early childhood.  Additionally, the 2
nutritive benefits of breast milk can be seen to enhance cognitive development, as demonstrated 
when comparing intelligence quotients between children who were breastfed for seven months as 
opposed to those who were only breastfed for one month.  Lastly, breast milk provides 3
invaluable immune system benefits, which reportedly could prevent up to 13% of child deaths 
worldwide.  4
Although breastfeeding has been proven to be beneficial to infants and mothers alike, 
many women are unable to breastfeed. One of the major reasons that can prohibit a mother from 
breastfeeding her child is her own health status, as women who are infected with HIV/AIDS or 
other chronic, blood-borne conditions are recommended not to breastfeed.  Additionally, some 5
mothers do not breastfeed their infants because child may have a metabolic disorder whereby 
they cannot digest breast milk or they are unable to latch on to the breast.  Lastly, some mothers 6
do not breastfeed their children due to cultural factors. For instance, some mothers may work in 
places that do not allow them to pump milk during the day, while others may not have adequate 
support at home or not have anyone in their lives who has breastfed in the past.  All of these 7
1 J. Wagner, C. Hanson, and A. Berry, “Donor Human Milk for Premature Infants: A Review of Current Evidence,” ​ICAN: 
Infant, Child, & Adolescent Nutrition​, vol. 5, no. 2, pp. 71-77, 2013. 
2 “Breastfeeding and the Use of Human Milk,” ​American Academy of Pediatrics​, vol. 129, no. 3, Mar. 2012. 
3 M.S. Kramer, “Breastfeeding and Child Cognitive Development,” Archives of General Psychiatry, vol. 65, no. 5, pp. 578-584, 
2008. 
4 G. Jones, R.W. Steketee, R.E. Black, Z.A. Bhutta, S.S. Morris, , & Bellagio Child Survival Study Group, “How many child 
deaths can we prevent this year?” ​The Lancet​, vol. 362, pp.65-71, 2003. 
5 “Acceptable medical reasons for use of breast milk substitutes,” World Health Organization, Geneva, Switzerland, 2009. 
6 J.H. Kim and S. Unger, “Human milk banking,”​ Paediatrics Child Health​, vol. 15, no. 9, pp. 595-598, Nov. 2010. 
7 US Department of Health and Human Services. "The Surgeon General's call to action to support breastfeeding." 2011. 
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factors can discourage mothers from breastfeeding their children, putting these infants at an 
unfortunate disadvantage. 
 
1.2 Breast Milk Banking Improves Access to Breast Milk for Infants in Need 
In an attempt to increase access to human breast milk that is free from contamination 
there has been a global emergence of human breast milk banks to help infants in need. Table 1 
compares the number of milk banks, pasteurization method and quality control procedures of 
human breast milk banks around the world. 
 
Table 1. ​Comparison of Human Breast Milk Banks Globally 
Country/Region Number of Milk Banks Pasteurization Method Quality Control 
Procedures 
North America 26 Holder Method Bacterial Culturing 
Europe 214 Varies Varies 
Brazil 210 Holder Method Dornic Acidity, 
Bacterial Culturing, 
Crematocrit Testing 
South Africa >12 Flash Pasteurization Bacterial Culturing 
India 14 Holder Method Bacterial Culturing 
 
Over the past several decades, North America has seen a growth in traditional human 
breast milk banking, as indicated by the 26 human breast milk banks that are currently a part of 
the Human Milk Banking Association of North America. In comparison with North America, 
there are 214 human breast milk banks in Europe that are a part of the European Milk Bank 
Association. France has the highest number of human breast milk banks with 36, whereas 
12 
 
countries like Russia and Portugal have 1 human breast milk bank each.  However, as indicated 8
in ​Table 1​, operating procedures vary amongst the EMBA members.  
In considering countries in the developing world, Brazil has the most extensive and long 
standing human breast milk banking system in the world. They have 210 breast milk banks 
nationwide to support 3 million annual births. This extensive network has been a key factor in 
decreasing the infant mortality rate by 73% from 1985 to 2013.  In contrast to Brazil, South 9
Africa only has 12 breast milk banks. These breast milk banks face challenges of resource-poor 
settings where they struggle with inadequate staffing and a lack the necessary funds for 
equipment maintenance.  Conversely, India is seeing substantial growth in the milk banking 10
industry. Although are only 14 human breast milk banks nationwide, which is not enough to 
support over 25 million infants born annually, the Indian Academy of Pediatrics’ has made huge 
strides in creating and updating a comprehensive set of guidelines for milk banks in India.  11
 
1.2.1 Breast Milk Banking Process Overview 
 
Figure 1. ​Schematic of operational flow for breast milk banking.  
 
To verify the safety of donated human breast milk for consumption, human breast 
milk banks have implemented controls to ensure there are no contaminants or dangerous 
substances in the milk. The primary opportunities for contamination include the initial 
lactation and pumping by the mother, initial storage, transportation to the milk bank, 
reception at the milk bank, and operational operational processes within the bank itself. 
8 “EMBA,” European Milk Bank Association, 2016. 
9 F. Pires. (2014 Dec 2). Learning from Brazil’s success with milk banks. ​University of Michigan News. 
10 ​I. Coutsoudis, M. Adhikari, N. Nair, and A. Coutsoudis, “Feasibility and safety of setting up a donor breastmilk bank in a 
neonatal prem unit in a resource limited setting: An observational, longitudinal cohort study,” ​BMC Public Health​, vol. 11, no. 
356, 2011. 
11 K. Bharadva et al., “Human milk banking guidelines,” ​Indian Pediatrics​, vol. 51, no. 6, pp. 469-474, 2014. 
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As such, a stringent quality control process must be implemented to ensure consumers are 
not exposed to harmful contaminants.  
Through a review of current best practices of safety controls employed by human 
breast milk banks, the process outlined in​ Figure 1​ was found to be the general breast 
milk banking procedure to verify and ensure the safety of donated human breast milk. 
The general milk banking process includes donor testing, breast milk donation, 
pasteurization & screening tests, storage of the milk, and distribution to infants.  12
The process begins with the human breast milk bank testing the donor’s blood 
before she donates to ensure that the milk will not be able to transmit diseases such as 
hepatitis B/C, syphilis or HIV/AIDS. Further the donor’s blood is tested to ensure that it 
does not contain traces of illegal drugs, certain medications, tobacco products, herbal 
supplements, or environmental contaminants as the presence of these substances in breast 
milk can negatively impact a child’s health.  Once a donor has been successfully 13
screened, she can donate human breast milk that may be collected at home or at the milk 
bank. 
Once the human breast milk has been donated, human milk banks will pasteurize 
the collected milk to destroy any harmful bacteria present in it. Following pasteurization 
the donated human breast milk is cultured, often times by a microbiological lab that is 
external to the milk bank itself.  
After the donated human breast milk has undergone pasteurization and culturing, 
it should be stored at four degrees Celsius for up to 48 hours and frozen at negative 20 
degrees Celsius for three to six months.  Finally, the donated human breast milk is 14
distributed to mothers and infants in need. 
 
1.2.2 Current Methods for Pasteurization at Milk Banks 
The goal of pasteurization is to limit the risk of harmful bacteria present in 
donated human breast milk. Pasteurization methods use high heat levels to inactivate 
12 K. Bharadva et al. 
13 K. Bharadva et al. 
14 ​D. Silvestre, M.C. Löpez, L. March, A. Plaza, and C. Martinez-Costa. “Bactericidal activity of human milk: stability during 
storage,” ​British Journal of Biomedical Science​, vol. 63, no. 2, pp. 59-62, 2006. 
14 
 
bacteria, viruses, and other potential pathogens.  Although industrial-grade 15
pasteurizations are used in the dairy industry to ensure safety of dairy milk, many human 
breast milk banks are unable to afford this type of technology because they can cost up to 
$60,000.  Instead, Holder pasteurization is a common method where donated human 16
breast milk is heated up to 62.5 degrees Celsius for 30 minutes in a shaker water bath.  17
Another method called flash pasteurization involves heating the donated human breast 
milk up to 72ºC for 16 seconds.  These methods are widely practiced around the world at 18
human breast milk banks. Depending on the human breast milk bank, pooling of the 
donated human breast milk from multiple donors may occur to maximize nutritional 
content and uniformity.  While pooling may overall enhance the quality of the donated 19
human breast milk, contamination makes it difficult to determine the source.   20
Unfortunately, there is no guarantee pasteurization will destroy all of the harmful 
bacteria present in the donated human breast milk. In addition, pasteurization may 
negatively affect beneficial properties of the donated human breast milk. It generally does 
not alter nutritional carbohydrate, fat, and salt composition, but the high level of heat may 
reduce or destroy beneficial immune factors like IgA, IgG, IgM, and lactoferrin.  21
However, without an alternative method, human breast milk banks continue to pasteurize 
the donated breast milk to to ensure safety for infants. 
 
1.2.3 Cost and Resource Efficiency of Culturing Method for Screening Breast Milk 
Bacterial culturing may be done before and/or after to verify the success of 
pasteurization in the human breast milk banking process. It is practiced pre-pasteurization 
and post-pasteurization to determine the microbial content in donated human breast milk. 
Pasteurization methods often do not maintain a high constant temperature resulting in 
15 ​“Strengthening Human Milk Banking: A Global Implementation Framework,” PATH, 2013. 
16 S. ​Landers, and K. Updegrove, “Bacteriological screening of donor human milk before and after Holder pasteurization,” 
Breastfeeding Medicine​, vol. 5, no. 3, pp. 117-121, 2010. 
17 ​K. Bharadva et al. 
18 ​W. E. Corpelejin, et al. 
19 “Strengthening Human Milk Banking: A Global Implementation Framework,” PATH, 2013. 
20 ​“Strengthening Human Milk Banking: A Global Implementation Framework,” PATH, 2013. 
21 W. E. Corpelejin, et al. 
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remaining bacterial contamination.  Consequently, human breast milk banks send out 22
small samples or batches of donated human breast milk to a microbiological lab to 
determine if any bacteria grows within a 24 hour period. Depending on the guidelines of 
the human breast milk bank, if bacterial colony forming units (CFUs) are found above a 
certain limit, the milk is likely discarded to ensure microbiological quality.   23
Even though donated human breast milk could be heavily contaminated, bacterial 
culturing is not standardized amongst human breast milk banks around the world. It is a 
costly and lengthy process, so human breast milk banks must balance quality assurances 
along with their own resources and financial limitations. Using a sterile laboratory and 
hiring a highly trained laboratory technician quickly raise the costs for bacterial culturing. 
Additionally, microbiological testing results are not instantaneous. 
Measuring the full financial impact of human breast milk banks around the world 
is a challenge. However, the processing and operating costs of donated human breast 
milk appear to be negligible compared to the cost of treating vulnerable infants with 
immune system diseases and complications.  Bacterial culturing is important in 24
monitoring the success or failure of pasteurization methods to determine contamination 
and prevent future problems for infants. Therefore, human breast milk banks may be a 
more cost effective solution for infants and mothers in need. 
 
1.3 Problem Statement 
Current methods of culturing bacteria when testing samples is expensive and 
time-consuming for milk banks in both developed and developing communities. To reduce these 
factors, milk banks are in need of a rapid, affordable, accurate, and sensitive sensor that is able to 




22 ​K. Bharadva et al. 
23 ​K. Bharadva et al. 
24 J.H. ​Kim, and S. Unger, “Human Milk Banking,” ​Paediatrics & Child Health,​ vol. 15, no. 9, pp. 595–598, 2010. 
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1.4 Literature Review: Existing Diagnostics Technology for Human Breast Milk 
The following table compares diagnostic technologies for breast milk and their varying 
purposes, detection methods, prices, applications, and times required to obtain results. The 
Happy Vitals test kit and the Milk Screen strips are commercially available, while the Biosensors 
for Quality Assurance of Dairy Products, Food Biosensors, and Electrochemical DNA-based 
biosensor, and Poly Methyl methacrylate (PMMA) “Lab-on-a-chip” for Human Breast Milk 

























Table 2. ​Diagnostic products and technologies for milk on the market and under development. 
Product Component Detected Detection Method Price Application Setting Time 
Happy Vitals  25 Macronutrient levels, 
heavy metals, vitamins, 
minerals 





available; lab screening 
of samples sent from 
mothers at home 
3-5 days 
Milk Screen by 
Upstring Strips  26
Alcohol, 
Docosahexaenoic acid 
Colorimetric test strip  $14.99 for 
eight strips 
Commercially 
available; testing at 
home 
2 minutes 
NeoGen Tests for 
Dairy Products  27
 β-Lactoglobulin 
(BLG), casein, total 
milk (casein and whey 
proteins), allergens,  
Screening microwell tests, 











Soleris System and 
Vials  28
E. coli​ O157:H7 Ready-to-use vials with 
colorimetric indicator, 









Biosensors for Quality 




Temperature, light, bacteria Variable, 
>$1,000 
Laboratory research, 
primarily cow milk 
Variable 
Food Biosensors  30 General quality, 
carcinagen aflatoxin 
M1 











Bacillus cereus DNA-based Au-nanoparticle 
modified pencil graphite 
electrode (PGE) 





Energy content as 
measured by fat, 
protein and lactose 
Cross-flow microfiltration 
structure 




25 “Tracking Better Health for Mom and Baby.” Happy Vitals. N.p., n.d. Web. 20 November 2017. 
26 “Milkscreen.” Milkscreen Home Test for Alcohol in Breast Milk. N.p., n.d. Web. 20 November 2017. 
27 “Total Milk/Casin/BLG.” NeoGen. Happy Vitals. N.p., n.d. Web. 20 November 2017. 
28 “​E. coli ​Vial.” NeoGen. Happy Vitals. N.p., n.d. Web. 20 November 2017. 
29 Pividori, Maria Isabel, Salvador Alegret. “Biosensors in Quality Assurance of Dairy Products.” Portable 
Biosensing of Food Toxicants and Environmental Pollutants. Eds. Dimitrios P. Nikolelis, et al. CRC Press, 2013. 
411-442. 
30 ​Ahmed, M. U., Zourob, M., & Tamiya, E. Food biosensors. Cambridge: Royal Society of Chemistry, 2017. 521 
pp. 
31 ​Izadi, Z., Sheikh-Zeinoddin, M., Ensafi, A. A., & Soleimanian-Zad, S. (2016). Fabrication of an electrochemical 
DNA-based biosensor for Bacillus cereus detection in milk and infant formula. ​Biosensors & Bioelectronics​, 
80​582-589. doi:10.1016/j.bios.2016.02.032 
32 Lai, M., Lai, C. T., Keating, A., Dell, J., & Liu, Y. Cross-flow microfiltration for lab-on-chip defatting of human 




1.5 Literature Review: Existing Low-Cost, Microfluidic Sensors for Bacterial Detection 
1. Paper sensors for bacterial detection in dairy milk and orange juice  33
Paper sensors exist in a simple kit that would allow for untrained personnel to carry out 
sensitive, multiplexed detection ​E. coli​ in food samples. These paper based sensors utilize 
sol-gel-derived silica inks placed by an ink-jet printing technique to produce colorimetric 
results, which can be judged by the human eye or a combination of digital camera and 
image analysis software. 
 
2. Integrated capture, concentration, polymerase chain reaction, and capillary 
electrophoretic analysis of pathogens on a chip  34
This sensor is comprised of micropumps and valves on a PMMA chip that utilizes PCR 
and amplicon separation for selective targeting of pathogens. As this sensor maintains 
advantages such as analysis speed and compact size, it also boasts detection sensitivity 
and analysis volume that are capable of identifying a dangerous pathogen with 
contemporary significance at clinically relevant sensitivities (O157 ​E. coli​ at 0.2 
CFU/µL). 
 
3. Optical enzyme-linked immunosorbent assay on a strip for detection of Salmonella 
typhimurium  35
This rapid and sensitive enzyme-linked immunosorbent assay (ELISA) on an 
immunochromatographic strip utilizes colorimetric and chemiluminescent techniques to 
detect ​Salmonella typhimurium​. It can quantitatively measure the pathogen in the range 
of 9.2×10​3​ to 9.2×10​6​ CFU/mL within 20 min (colorimetric method) and 16 min 
(chemiluminescent method). 
 
33 Hossain, S. M., Ozimok, C., Sicard, C., Aguirre, S. D., Ali, M. M., Li, Y., & Brennan, J. D. Multiplexed paper test 
strip for quantitative bacterial detection. ​Analytical and Bioanalytical Chemistry​ 2012, ​403​(6), 1567-1576. 
doi:10.1007/s00216-012-5975-x 
34 ​Beyor, Nathaniel et al. “Integrated Capture, Concentration, PCR, and Capillary Electrophoretic Analysis of 
Pathogens on a Chip.” ​Analytical chemistry​ 81.9 (2009): 3523–3528. ​PMC​. Web. 5 Dec. 2017. 
35 Park, Sojung, Yong Tae Kim. “Optical Enzyme-linked Immunosorbent Assay on a Strip for Detection of 




4. Microfluidic Assay for Continuous Bacteria Detection Using Antimicrobial Peptides 
and Isotachophoresis   36
This assay utilizes an electrophoretic focusing technique called isotachophoresis to 
establish a channel of heavily concentrated antimicrobial peptides (AMPs). The 
contaminated fluid travels down this channel and the bacteria is separated and from the 
AMPs where its fluorescence signal to provide a detectable and quantifiable 
measurement. 
 
1.6 Field Review: Capturing Customer Desired Outcomes 
1.6.1 Mothers’ Milk Bank of San Jose 
 
Figure 2. ​Schematic of operational flow at Mother’s Milk Bank in San Jose, California. 
 
A visit to Mother’s Milk Bank (MMB) in San Jose, California provided insight to 
the industry and explained the bank’s processes.   37
To begin, mothers who have passed the blood test screening pump their excess 
milk into glass or plastic containers, package the containers in a cooler, and ship the 
cooler to MMB. Upon reception of the shipments, MMB slowly thaws the milk breast 
milk to keep the milks live tissue intact. Donations from about three donors are pooled 
and stored in glass jars. The jars are then pasteurized at 62.5ºC for 30 minutes. After 
pasteurization, a sample from each batch of pooled milk is cultured in a lab and a 
microbiologist screens for colony-forming units. A significant portion of the donated 
milk is thrown away due to contamination, but loss at MMB San Jose is about half the 
rate at other milk banks in the United States. Clean milk is stored  in -20ºC freezers 
36Schwartz, O., & Bercovici, M. (2014). Microfluidic Assay for Continuous Bacteria Detection Using Antimicrobial Peptides and 
Isotachophoresis. ​American Chemical Society Publications,86​. Retrieved December 5, 2017. 
37 Sakamoto, Pauline. “Mother's Milk Bank Tour and Informational Interview.” 20 Oct. 2018. 
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before being donated to infants in hospitals and homes, where it can be refrigerated for 
24-48 hours. 
The most common contaminant in donated human breast milk ​after​ pasteurization 
is ​Bacillus cereus. ​MMB attributed this contamination to improper cleaning of the 
mother’s pumps when they are expressing, but the proliferation of ​Bacillus cereus ​is 
accelerated during pasteurization. 
The demand for donated human breast milk from MMB surpasses the supply, 
which is attributed to the promotion of human breast milk over formula by the private, 
for-profit milk bank Prolacta. The existence of online milk banking—despite being illegal 
in the state of California—evidences inadequate supply of donated breast milk and 
mothers’ willingness to obtain it. Additionally, a lack of regulation prevents milk from 
reaching infants high-risk who need it most. Rather, infants drinking milk obtained via 
online avenues are 6 months old on average. In addition to feeding infants, human breast 
milk is the only known treatment for necrotizing enterocolitis, a gangrene in the gut. 
The existing standards  place strict limits on the permissible contamination; 
federal organization recommend that milk banks “kill all pathogens” in stored milk, 
creating a zero tolerance for colony forming units. Elimination of these pathogens 
through pasteurization, however, results in a loss of about 20% of the naturally occurring 
immune factor IgA. 
 
The criteria for a sensor to detect ​E. coli​ were outlined as follows: 
● Objective results that eliminate the risk of human error in interpreting results, 
preferable standard device that reads and displays quantifiable results 
● Limit of detection 10​4 ​CFU/mL 
● Prove that milk does not need to undergo pasteurization 
 
1.6.2 PATH  38
PATH is an international non-governmental organization (NGO) that leads global 
38 ​PATH Informational Interview [Telephone interview]. (2017, December 4). 
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health innovation by accelerating innovation across five different platforms: vaccines, 
drugs, diagnostics, devices, and system and service innovations.  Dr. Kiersten 39
Israel-Ballard and Kimberly Amundson provided insight to PATH’s mission, projects, 
and resources they apply across the globe. 
As a body working to improve health equity and innovating medical technology, 
PATH provides expertise and tools to niche markets in order to break down barriers and 
save lives. One of such markets include the Maternal Health sector. 
As stated previously, there are no standards for storage and treatment of donated 
human breast milk in human breast milk banks across the globe. While different 
governance bodies have individual standards, human milk banks across the globe have 
various practices to meet such standards. In an effort make improvement, PATH has 
released national guidelines for human breast milk banks in India to “ensure timely 
initiation of breastfeeding and promote breastfeeding practices.”  By collecting feedback 40
from across the globe, PATH has created their Global Implementation Framework to 
share information on best practices surrounding this sector.  
Like Mother’s Milk Bank of San Jose, PATH described challenges surrounding 
the human breast milk banking industry. They highlighted that many banks outsource 
testing in order to determine if contamination is present within samples.  This outsourcing 
is both expensive and time-consuming, so professionals in underdeveloped settings often 
do not have access to such resources and are in need of a simple, rapid, and point-of-care 
solutions.  
Lastly, PATH shed light on the implications that the sensor could potentially have 
with breastfeeding mothers who may eventually see this product go to market. According 
to feedback they collected, a common theme with mothers is that they never feel like they 
are enough. Mothers feel like they could produce more milk with greater nutritional value 
in order to provide the best care possible for their children. As a team working to develop 
39 PATH: Driving Transformative Innovation to Save Lives. (n.d.). Retrieved December 5, 2017, from 
https://www.path.org/index.php 
40 ​Gurnani, V., Khera, A., Deb, S., Prabhakar, P. K., Singh, A., Kaujia, R., . . . Bhart, V. (n.d.). ​National Guidelines 
on Lactation Management Centres in Public Health Facilities​. Government of India: Child Health Division: 
Ministry of Health and Family Welfare. 
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a resource that could be perceived as a new tool to “judge” a mother’s milk, our team 
must be cognizant of the ramifications that can result and its effects on mothers across the 
globe.  
 
1.6.3 Sion Hospital, Mumbai, India  41
In June of 2017, one member of the 2016-17 senior design team, Callie Weber, 
and one member of the EWH team, Karen Mac, toured the birthing unit, collection sites, 
milk banking lab, and microbiology departments led by the PATH team at the Sion 
Hospital in Mumbai, India. Here the team gained valuable insight for the future direction 
of MilkGuard. 
They learned that the sensor must guarantee results with 99% assurance in order 
to be used in the milk bank setting. It must eliminate false positives, having the ability to 
differentiate between the detection of ​E. coli​ and other pathogens. It must also eliminate 
false negatives due to alternative cell lines of ​E. coli​ present in the sample. 
The sensor must be able to detect other potential contaminants in breast milk in 
order to be a viable alternative to bacterial culturing. Currently, Sion Hospital is mainly 
concerned with the contaminants: ​Staphylococcus aureus, Asilobacterium, Klebsiella, 
Enterobacterium, Enterococcus​, and ​Bacillus​, and gram-negative bacteria. 
The strip’s colorimetric results should have a strict limit indicating the 
permissible level of contaminant versus an unusable one. A quantification method 
integrating a mobile phone application could potentially be employed, but the use of this 
platform should take into consideration the willingness and aptitude of the hospital 
employees to adopt its use. However, should it be used, then the solution should be 
developed for Android given the predominance of Android users over iPhone users in 
India. The hospital is currently making the transition from paper-based records to an 
electronic medical record system, indicating the under resourced context in which the 
strip could be used. 
41 Weber, Callie, Mac, Karen. “MilkGuard: Mumbai Field Research Travel Report.” June 2017. 
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The Sion Hospital Breast Milk Bank currently performs bacterial culturing before 
and after pasteurization, but still pasteurizes all of their milk due to limited timing and 
resources. A sensor with a limit of detection of 10​3​ CFU/mL could stand in as a substitute 
to culturing pre-pasteurization. This would allow for contaminated milk to be thrown out 
without unnecessarily pasteurizing it. Additionally, the sensor would allow for milk to be 
safely pooled into batches, which is the preferred method of most milk banks (including 
Mother’s Milk Bank of San Jose) because it standardizes the nutritional content of the 
donor milk for all recipients. 
 
1.6.4 Mothers’ Milk Bank of Aurora 
Mother’s Milk Bank of Aurora maintains all of the same HMBANA standards 
and regulations as Mother’s Milk of San Jose. Rather than screening their milk on-site, 
this bank outsources the bacterial culturing tests to a laboratory, which can take up to 
three days for transportation, testing, and results. Given the bank’s holistic approach to 
maternal health, they brought to attention the psychological impact which a product that 
qualifies the viability of a mother’s breast milk could have on a mother who is already in 
a compromised or sensitive state. 
 
1.6.5 Northwest Mothers Milk Bank of Portland 
Northwest Mothers Milk Bank adheres to the standards set by HMBANA. This 
bank also outsources their bacterial culturing tests to a laboratory, taking up to three days 
for transportation, testing, and results. The bacterial tests are unspecific. Although this 
bank also follows a “zero tolerance” policy for bacterial contamination, they retest any 
results that come back between 10 and 50 CFU/mL. Sometimes the milk resulting in 10 
to 20 CFU/mL contamination can successfully pass a retest and be cleared for 
distribution. The milk between 20 and 50 CFU/mL usually fails a retest. This bank only 
performs post-pasteurization tests. They cannot justify paying for pre-pasteurization tests 
due to the high percentage of milk that passes the tests after pasteurization. However, 
they did recognize that a fairly cheap method for pre-pasteurization screening, such as 
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our device, would be useful in eliminating the pasteurization process for milk that is 
highly contaminated. This milk would instead be thrown away initially, instead of 
undergoing the pasteurization process, waiting for test results, then throwing it away. 
 
1.7 Project Goal 
The overall goal of the project is to develop a low-cost, polymer-based sensor that detects 
Escherichia coli​ bacteria in donated human breast milk. The sensor aims to enable easy, efficient 
detection, eliminating the need for pasteurization of uncontaminated donated human breast milk 
in breast milk banks. 
 
1.8 Project Objectives 
The sensor’s development is focused on time and cost factors that are associated with the 
pasteurization and culturing of cells within donated human breast milk at established breast 
banks. Based upon customer interviews with Mother’s Milk Bank of San Jose, PATH, and other 
milk banks associated with the Human Milk Banking Association of North America, criteria 
include, but are not limited to: 
● Sensing contamination of at least 10​3​ CFU/mL 
● Obtain objective, precise, and quantifiable results 
● Mitigation of false positives and false negatives 
 
Our overall goal is to create a simple, affordable, and easily manufacturable sensor that 
can consistently test for a variety of pathogens found within donated human breast milk in both 
underdeveloped and developed industry settings. To do so, we plan on taking the following 
steps: 
● Replicate detection method of ß-galactosidase in breast milk 
● Ensure detection method of ß-galactosidase is compatible in breast milk 
● Determine sensor sensitivity 
● Improve uniformity of biological reagent deposition on sensor 




1.9 Solution Ideation 
1.9.1 Existing Sensor Mechanism Overview 
The proposed method of using the paper based sensor consists of the following steps: 
1. E. coli​ cells in human breast milk sample will be lysed prior to use of paper based 
sensor. 
2. The bottom part of the sensor will be dipped into the milk sample. 
3. The enzymes from the ​E. coli​ cells will hydrolyze the substrate on the sensor, 
causing a blue color to form in the presence of contamination greater than 10​3 
CFU/mL. 
4. Calorimetric results will be read by user to determine safety for consumption. 
 
1.9.2 Opportunities for Improvement Upon MilkGuard Sensor 
1.   Lower limit of detection to 10​3​ CFU/mL 
Since trace amounts of bacteria are capable of compromising an infant’s growing 
immune system, the sensor must be able to detect low concentrations to ensure infant 
health safety. 
2.   Develop a multiplexed sensor to test for additional contaminants 
The MilkGuard sensor could be adapted to test for additional pathogens that are of 
primary concern in the storage of breast milk. The sensor could have the ability to test 
multiple pathogens simultaneously. 
3.   Improve dispensing techniques 
Create an easy method for users to deposit milk on the strip. 
4.   Improve manufacturability 
Implement the use of gel-printing to rapidly create more uniform test strips. 
5.   Optimize packaging 
Design a package that will provide satisfactory storage, enabling the sensor to have a 
long shelf life and still be easy to open. 
6.   Develop mobile image capture for quantification of bacterial contamination 
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A mobile phone application that could provide real time quantification of 
contamination would greatly benefit the end user. As android phones are becoming 
more popular, a mobile platform would allow greater access to powerful data 
analysis. 
 
1.9.3 Anticipated Modifications to Mechanism 
1. ß-galactosidase v. ß-glucuronidase. ​The current prototype senses the presence of ​E. 
coli ​via the presence of ß-glucuronidase, however, sensor’s specifications could be 
improved by changing the detection method to sense ß-galactosidase. The detection 
of ß-galactosidase is a known and effective standard method of detection for many ​E. 
coli ​strains.  In collaboration with a microbiologist, Dr. Craig Stephens, PhD, 42
changing the enzyme detected could improve the sensor’s functionality as lactose, 
present in both dairy and human breast milk, catalyzes the production of 
ß-galactosidase in strains with an intact LacZ gene.  This alteration has potential to 43
improve the functionality of the sensor as it is used in a breast milk buffer.  
2. Uniform Printing. ​The​ reagents could be deposited onto the paper surface via ink-jet 
printing. This structured-layers approach prints a capture layer (polyvinyl amine), a 
lower sol–gel-derived silica layer, the reagent, and a top silica layer, with reagents 
entrapped in corresponding zones.  To optimize the printing performance (ability to 44
jet the inks) as well as the enzyme activity, the different printing solutions could be 
modified by the addition of glycerol, to control viscosity, and Triton X-100, to control 
surface tension.  The piezoelectric Epson Stylus C88 Inkjet Printer will be used to 45
42 ​Rivas, L., Mellor, G. E., Gobius, K., & Fegan, N. (2015). ​Detection and typing strategies for pathogenic 
Escherichia coli​. New York: Springer. 
43 ​MilkGuard Informational Interview [Personal interview]. (2017, November 7). 
44 Li, Jia, Fabrice Rossignal, Joanne Macdonald. Inkjet Printing for biosensor fabrication: combining chemistry and 
technology for advanced manufacturing. Royal Society of Chemistry 2015 ​15, 2538-2558. DOI: 
10.1039/C5LC00235D 
45 S. M. Zakir Hossain, Roger E. Luckham, Anne Marie Smith, Julie M. Lebert, Lauren M. Davies, Robert H. 
Pelton, Carlos D. M. Filipe, and John D. Brennan. Development of a Bioactive Paper Sensor for Detection of 
Neurotoxins Using Piezoelectric Inkjet Printing of Sol−Gel-Derived Bioinks. Analytical Chemistry 2009 81 (13), 
5474-5483 DOI: 10.1021/ac900660p 
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deposit the layers and manufacture sensors on Whatman Grade 1 Qualitative Filter 
Paper, improving the sensor’s deposition uniformity and economy of scale. 
3. Immunomagnetic Separation.​ IMS would allow the sensor to selectively detect a 
target pathogen. It allows a target organism to be separated from a food matrix and 
background microflora, and concentrated into a smaller sample volume, which would 
make it easier for a paper strip to detect a concentrated ​E. coli​ sample.  46
 
The sensor’s efficiency will be improved by streamlining time-consuming, 
pre-treatment steps onto the sensor. Its applicability will be enhanced by lowering the 
sensor’s limit of detection, and its reliability will be guaranteed through the mitigation of 
false negatives and false positives. Finally, its viability as a consumer product will be 
enabled through manufacturable, scalable preparation. 
 
1.10 Key Deliverables 
The key deliverables of the project are the following: 
1. Produce consistent prototype sensor. 
2. Verify the viability of ß-galactosidase detection in human breast milk. 
3. Generate standard concentration curve corresponding to colorimetric results for 
ß-galactosidase detection. 
The expected results are the following: 
1. Prepare the sensor for production using IMS for cell-lysing and an inkjet printer for 
uniform deposition of gel on paper sensor. 





46 Tu S-I, Reed S, Gehring A, He Y, Paoli G. Capture of Escherichia coli O157:H7 Using Immunomagnetic Beads of 




1.11 Team and Project Management 
The team has been communicable, organized, and proactive with the goals and progress 
of the project each week, quarter, and over the course of the year. Effective communication and 
record keeping prevent misunderstandings and allow for discussion in the case of disagreements. 
Each teammate’s dedication enables discovery to be made, and the team’s understanding of how 
each teammate can contribute given their strengths, schedule, and demands at a given point in 
time allows for dynamic collaboration and delegation.  
The team agreed upon a Team Charter at the beginning of the project. The Charter 
outlined objectives, responsibilities, consequences, milestones, and expectations for the duration 
of the project. The agreement ensured that all team members were on the same page regarding 
what was expected of them and prevented conflict from arising. 
Through collaboration Engineering World Health and the School of Engineering, two 
faculty advisors on the project contributed their expertise. Dr. Parker from the Public Health 
Department and Dr. Kim from the Bioengineering Department served as these advisors. The 
bioengineers met with Dr. Kim weekly to discuss experiment results, propose goals for the 
following week, and talk through concepts. They also met with Dr. Parker periodically to discuss 
the future of the project and potential opportunities for advancing the project. The EWH students 
attended a class with Dr. Parker each week as well as a weekly meeting with the bioengineering 
students to share ideas. 
Weekly meetings were a platform to share findings in the lab, explain conceptual design 
components, brainstorm ideas, hypothesize outcomes, and outline action items. The action items 










Table 3: ​Team Member Roles and Responsibility 
Team Member Role 
Nick Kikuchi 
Bioengineering 
● Correspondent with Dr. Mobed-Miremadi 
● Lead in gel entrapment procedures 
● Maintains experiment log 
Maggie May 
Bioengineering 
● Correspondent with Mother’s Milk Bank and Dr. Barber 
● Thesis organization and documentation 
● Runs assays alongside Nick and Matt 
Matt Zweber 
Bioengineering 
● Correspondent with Dr. Stephens 
● Orders materials and manages inventory 
● Organizes results of collected data 
Sara Kelly 
Public Health 
● Assists in background research  
● Prepares content for conference applications 
Karen Mac 
Public Health 
● Mumbai Trip Researcher 
● Prepares content for conference applications 
Maya Tromburg 
Public Health 
● Assists in background research  
● Prepares content for conference applications 
Dr. Unyoung Kim 
Bioengineering 
(Advisor) 
● Medical device advisor provides insight into experimental 
design 
● Guides team in experiment design and data organization 
Dr. Michele Parker 
Public Health  
(Advisor) 
● Advisor provides feedback regarding design application 





● Biomolecular advisor provides insight into experimental design 
● Guides team in experiment design and data organization 
 
1.12 Budget  
Our budget mainly consisted of lab supplies. We anticipated buying most of the items 
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that we did end up purchasing. These items were reasonably priced within our budget. The only 
surprise was purchasing $800 worth of breast milk, which happened over a slight 
miscommunication. Fortunately, we were able to pay for the breast milk and continue to 
purchase other necessary materials. 
 
1.13 Timeline 
The progress made on the development of the sensor was limited by the nine month time 
period allotted for work. The need research and establishing familiarity with previous laboratory 
protocols took place from September-December 2017. A majority of the laboratory work took 
place from January-June 2018. 
 
CHAPTER 2: SOLUTION OVERVIEW AND DESIGN RATIONALE 
 
2.1 Overview of Sensor Design and Application 
The sensor relies on the indirect detection of ​E. coli​ through the binding of the enzyme 
ß-galactosidase with the substrate X-gal. ß-galactosidase is expressed by ​E. coli, ​and as a 
reporter gene expressed in the lacZ operon, its presence therefore indicates the presence of ​E. 
coli.​ Upon X-gal hydrolysis of ß-galactosidase, galactose and 5-bromo-4-chloro-3-hydroxyindole 
is yielded. The 5-bromo-4-chloro-3-hydroxyindole then spontaneously dimerizes and is oxidized 
into 5,5'-dibromo-4,4'-dichloro-indigo, an intensely blue, insoluble product. In order to obtain 
this blue product, the milk sample must be prepared with ​E. coli​ and lysed. The sensor must 
entrap X-gal within a platform upon which the milk sample can be deposited so that the reaction 






Figure 3. Sensor Schematic and Application.​  The ß-galactosidase, expressed by E. coli, resides within the milk 
sample. A drop from the milk sample is deposited onto the central sensor, which contains the substrate X-gal. The 
color change produced within the sensor can then be compared to the key, which indicates the concentration of 
bacteria contamination corresponding to the observed color change. 
 
2.2 Key Constraints: Customer Needs and System-Level Requirements 
The sensor is designed to meet the needs of breast milk banks around the world, 
particularly those in developing countries. The World Health Organization outlines the 
ASSURED criteria for point-of-care devices: affordable, sensitive, specific, user-friendly, rapid 
and robust, equipment-free and deliverable to end-users. Thus, criteria were adopted from these 
recommendations for the design of the sensor: 
 
Affordable: ​The device must cost less than $1.00 to ensure accessibility for low-resource 
settings. 
Sensitive: ​The device must have a low limit of detection (preferably 10​3​ CFU/mL). 
Specific:​ The device must consistently detect certain bacteria. Ideally, it must guarantee 
that it is not detecting interference from a non-targeted bacteria. 
Minimal pretreatment of sample: ​The device must be user friendly and not require 
additional equipment. 
Quantified, Objective Results: ​The sensor must clearly indicate the presence or absence 
of bacteria. 
Rapid: ​The device must provide results in under 24 hours. 
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Frugal: ​The device must be easy to dispose and portable. 
 
2.3 Detailed Design Description 
2.3.1 Indirect Biomolecular Detection Method 
ß-galactosidase is induced in ​E. coli​ cells by the lactose in human breast milk. 
Based off of this induction, X-gal is allowed to react with ß-gal. The color produced from 
X-gal hydrolysing ß-gal represents the indirect result of the concentration of ​E. coli​ cells 
in a sample. 
 
2.3.2 Lysing Step 
The lysing step prepares the cells such that the enzymes β-glucuronidase and 
β-galactosidase can access the substrate X-glucuronidase and X-galactosidase, 
respectively. Some methods permeabilize the cell membrane rather than break it down 
entirely. 
 
2.3.3 Gel Entrapment 
Gel entrapment is a key component to our sensors construction that allows for 
substrates to retain their bioactivity and functionality because they are able to sustain 
their native-state conformations.  Our team used this method to entrap our substrate 47
(X-gal) to retain its activity and replicate our assay on the polymer-based platform. 
 
2.3.3.1 Alginate Gel. ​Alginate is a naturally-occurring, water-soluble polymer that is 
composed of (1,4)-linked β-D-mannuronic and (1,3)-α-L-guluronic acid residues. As an 
organic copolymer, it is a cheap and thoroughly researched biomaterial that has multiple 
applications in microencapsulation of numerous substrates.  Alginate was chosen as a 48
47 D.-M Liu, I-W. Chen. “Encapsulation of Protein Molecules in Transparent Porous Silica Matrices via an Aqueous 
Colloidal Sol-Gel Process.” ​Department of Materials Science and Engineering, University of Pennsylvania. ​47 
(1999). 4535-4544. Web. 
48 Cheryl Simpliciano, Larissa Clark, Behrokh Asi, Nathan Chu, Maria Mercado, Steven Diaz, Michel Goedert, 
Maryam Mobed-Miremadi. “Cross-Linked Alginate Film Pore Size Determination Using Atomic Force Microscopy 
and Validation Using Diffusivity Determinations.” ​Journal of Surface Engineered Materials and Advanced 
Technology. ​3 (2013): 1-12. 
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method of entrapment and immobilization of biomolecules for a polymer-based platform. 
Due to its inertness, alginate gels allow biomolecules to retain their bioactivity without 
affecting the physical or chemical structures.   49
 
2.3.3.2 Rationale for Alginate Gel Compared to Other Entrapment Gels. ​Alginate gel 
was chosen as an entrapment technique over other methods including bioaffinity 
attachment, covalent bonding techniques, and silica sol-gel immobilization due to ease of 
fabrication, cost, and uniformity of its mesh and pore size. While the previous team used 
silica-sol gels as their entrapment mechanism, research proved that alginate acted as a 
more effective option. 
Bioaffinity attachment relies on cellulose binding domains (CBD) that tags and 
fuses the desired protein to the paper-based platform.  Covalent chemical bonding 50
immobilization relies on the presence of biomolecules and functional groups to create 
rapid immobilization on the paper platform through covalent bonds.  Silica sol-gels can 51
be created from a number of precursors including Si(OEt)​4​ (TEOS), Si(OMe)​4​ (TMOS), 
or sodium silicate. No matter the method of production, a sol-gel is created that is able to 
entrap biomolecules without interfering with that substrate’s bioactivity.  Though all 52
methods are effective for immobilization of biomolecules on paper-based platforms, 
alginate is superior due to its ease of manufacturability, cost, and uniformity. 
 
2.3.3.3 Comparison of Gel Entrapment Methods. ​Previously, the sensor’s design 
utilized silica sol-gels for the entrapment of biomolecules on a paper-based format. Our 
team explored the use of alginate gels due to its ease of manufacturability, cost, and 
uniformity.  
 
Table  4. ​Comparison of key characteristics between silica sol-gel and alginate.  
49 Interview with Maryam Mobed-Miremadi. 
50 Fanzhi Kong, Yim Fun Hu. “Biomolecule Immobilization Techniques for Bioactive Paper Fabrication.” ​Analytical 
and Bioanalytical Chemistry. ​403 (2012): 7-13. Web. 
51 Björn O. Roos, Antonio C. Borin, Laura Gagliardi. “Reaching the Maximum Multiplicity of a Covalent Chemical 
Bond.” ​Angewandte Chemie. ​119 (2007): 1491-1494. Web. 
52 Buckley, A.M., Greenblatt M.J. ​Chem. Ed. ​1994, 71 (7), 599. Web. 
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Characteristic Alginate Silica Sol-Gel 
Gel Fabrication  Simple Medium 
Cost Low Low 






In comparison between the use of alginate and silica sol-gels, four factors were 
considered: gel fabrication, cost, uniformity control, and sensor fabrication.  
 
Manufacturability. ​Both gels are easily fabricated. They both only require 
simple steps in order to create the gel solution (refer to ​Materials and Methods)​. 
However, silica sol-gels require the use of a vacuum filtration system and syringe filters. 
Silica sol-gels also require the addition of glycerol in order to adjust viscosity and surface 
tension that affected the gelation of the sol-gel. Alginate simply requires a cross-linking 
solution and drying times in order to create the gel-like structure. 
 
Cost. ​Silica sol-gel is very cheap, however alginate is significantly cheaper, 
therefore alginate proves to be a more economically viable option. 
 
Uniformity Control. ​The gels’ pore size are the key component that allow for the 
correct function of the gels on the sensor. The pores allow for the desired enzyme to 
travel through the pore and react with the biomolecules (substrates) that retain bioactivity 
while entrapped in the gel. Depending on deposition methods and production method, the 
pore size is variable. Originally, the silica sol-gels were pipetted directly into a mold to 
create the gel layers on the sensor. However, doing so relies heavily on human production 
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which often results in human errors and non-uniform deposition of the layer. This creates 
variable pore sizes. To fix such issue, we attempted use of printers to improve uniformity. 
Table 5 ​compares two printing methods.  
 
Table 5. ​Comparison of Hp Volumetric Dispenser vs. Inkjet Printing Methods 
Printer Advantages Disadvantages 
Hp Volumetric 
Dispenser  
● Allows for small volume 
deposition 
● Uniform layers  
● Rapid deposition 
● Requires the addition of surfactant to 
reduce surface tension. 
● Limits glycerol addition to 0% - 20% 
● Limits the amount of sodium silicate 
present in the gel 
Inkjet Printer ● Uniform layers  
● Rapid deposition  
● Requires compatible viscosity with 
ink cartridge 
● High potential to clog ink cartridge  
 
Though both methods of printing simplify manufacturability of such layers, they also 
pose additional complications. To meet the requirements of each printers, changes to the 
viscosity and surface tension of the gels must be variable. The biggest problem is 
balancing the composition of the gel with the parameters of the printers. The use of 
alginate allows for a simplified fabrication process of gels. Instead of needing to use a 
printer or chemical reactions to control and create uniform pore sizes, alginate 
automatically creates a uniform mesh. No matter the method of fabrication of such gel 
(refer to ​Materials and Methods​), the addition of cross-linking solution forces 
individual alginate strands to arrange in a uniform mesh with non-variable pore sizes.  
 
Sensor Fabrication. ​When utilizing silica sol-gel layers, the sensor requires the 
presence of three separate regions (refer to ​Sensor Design​). The first two layers are 
present to encapsulate ferric chloride and X-gus. The third layer acts as a hydrophobic 
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barrier to stop the blue color indication from progressing further down the paper. The 
adaptation of alginate on the sensor simplifies its manufacturability even more. Ferric 
chloride acts as a trivalent cross-linker for alginate and according to our research, does 
not necessarily catalyze the reaction between X-gal and ß-galactosidase. So, we can 
eliminate this region as it is not beneficial to the sensor’s functionality as it was 
previously when our method of indication relied upon the reaction between X-gus and 
ß-glucuronidase. In addition, the sensor’s alginate layer is created by using 3% alginate in 
order to create a pore size of approximately 3 nm. The alginate is mixed directly with the 
X-gal, so the cross-linked strands contain the X-gal within its structure, which eliminates 
the need to “entrap” the substrate between two distinct layers. Due to this fabrication 
method, we are able to deposit the sample directly onto the gel and, due to its 
predetermined pore size, enable the substrate to diffuse out of the gel to meet with the 
ß-galactosidase. The determined volume of sample mixed with the gel eliminates the 
need for the MSQ layer present in the initial sensor design. 
 
2.3.4 Sensor Design 
2.3.4.1 Revised Design​. After determining that a lateral flow method was not suitable for 
our sensor as it would allow for the possibility of contaminant entrapment within the 
paper pores, our design switched to a drop-based format. Here, a user would simply need 
to deposit a specific volume directly onto the sensor and allow the reaction to take place 





Figure 4. MilkGuard Revised Design. ​The sensor has a circular shape with an attached legend or key in the outer 
concentric circle to to allow for direct sample comparison. The alginate-based sample is located in the inner 
concentric circle where the reaction and blue color change will take place.  
 
2.4 Expected Results 
The sensor will produce a blue color change in the presence of ​E. coli,​ and a colorimetric 
spectrum corresponding to ​E. coli ​ concentrations will be developed.  
 
2.5 A Backup Plan 
In the case that the alginate capsules and slabs do not prove to be valid methods for X-gal 
entrapment and desired colorimetric indicators, the silica sol-gel method can be further explored 
and optimized. The HP Volumetric dispenser can be used to print the PVAm and XG layers, 








CHAPTER 3: MATERIALS AND METHODS 
 
3.1 Materials 
Pasteurized human breast milk was purchased from Mother’s Milk Bank (San Jose, CA) 
to test the efficacy of the detection method in solution and in alginate. SCU-104 ​Escherichia coli 
cells used to contaminate the human breast milk samples were given to us by Dr. Craig Stephens 
of the Santa Clara University Biology Department. The cells were grown in LB broth from 
Sigma Aldrich, Inc. (St. Louis, MI). The cells were lysed with Thermo Fisher’s B-PER Direct 
Bacterial Protein Extraction Kit, Lysozyme, and DNAse (Waltham, MA) or permeabilized with 
chloroform and sodium dodecyl sulfate (SDS) given to us by the Bioengineering Department of 
Santa Clara University (Santa Clara, CA). X-gal (5-Bromo-4-Chloro-3-Indolyl 
β-D-Galactopyranoside) from Thermo Fisher was used as the substrate in the enzyme-substrate 
reaction and dissolved in N,N-Dimethylformamide from Sigma Aldrich, Inc. The Bioengineering 
Department of Santa Clara University provided us with materials to make alginate capsules: 
alginate powder, 1.5% CaCl solution, 0.9% NaCl solution, 1 mL syringe, 18G 1 ½ inch precision 
needle, and a cell strainer. 
 
3.2 Methods 
3.2.1 Growth of ​E. coli​ Cells 
A swab of SCU-104 ​E. coli​ cells was placed into 2 mL of LB broth in a 10 mL 
tube. In early experiments, IPTG was mixed into the LB/cell mixture to induce the lacZ 
gene in the ​E. coli​ cells. However, IPTG was replaced with human breast milk for the 
majority of experiments. Once mixed, the 10 mL tube was placed into an incubator at 
37˚C and shaken at 225 rpm for approximately 10 hours. This time period allows the cells 
to surpass the log phase into their fully matured phase. Once incubated, the cells were 
removed and measured in a spectrophotometer. Absorbance measurements were taken at 





3.2.2 Dilution Preparation 
Dilutions are prepared to create a set of contaminated samples of donated human 
breast milk with known concentrations. Initially, dilutions were prepared concentrations 
ranging from 10​4 ​- 10​8 ​CFU/mL in order to ensure detection of higher concentrations of 
ß-galactosidase. Once our protocol had been validated at these higher concentrations and 
we obtained consistent detection, we expanded this range to create dilutions ranging from 
10​2 ​- 10​8 ​CFU/mL in an attempt to increase the sensor sensitivity. 
 
3.2.3 Lysing Step  
The ​E. coli​ cells are lysed in order to allow the ß-galactosidase protein to escape 
the cell membrane. To prepare each concentration of the serial dilution for completion of 
the Miller or B-PER protocols, the solutions are first centrifuged at 3000 g for 5 minutes. 
The supernatant is then extracted from each tube via pipet, and 400 µL of 50mM 
NaH​2​PO​4​ are added to each tube to resuspend the cell. Either B-PER solution or 
chloroform and SDS (sodium dodecyl sulfate) are added to each tube to lyse or 
permeabilize the cells. The cell solutions are then shaken at 225 rpm for 15 minutes. 
Once the cell membrane is lysed or permeabilized, the ß-galactosidase is able to react 
freely with the X-gal to produce a blue color. 
 
3.2.2.1 B-PER Protocol​. To lyse the cell membrane, 100 mL of B-PER solution is added 
to each concentration of ​E. coli​ solution in the serial dilution. The solution is made of 
~0.8% lysozyme, ~0.8% DNAase, and 98.4% B-PER by volume. The solutions are then 
incubated in a shaker for 15 minutes before adding X-gal. 
 
3.2.3 Preparation and Construction of Alginate Gel Sensor 
Using alginate as an entrapment mechanism allows for the simplification of the 
sensor design. With several comparably simple preparation methods, substrates can be 
easily entrapped within this gel and retain their bioactivity. This allows for our sensor to 
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contain one, all-inclusive layer that not only contains a bioactive substrate, but also 
contains the blue color change within a defined boundary. 
 
3.2.3.1 Alginate Mixing Preparation. ​Our group utilized a 3% alginate mixture because 
we wanted to obtain the structure and viscosity of 2% alginate mixture when 
cross-linking. Because the alginate is autoclaved to eliminate possibilities of 
contamination, the extreme heat causes the 3% mixture to shrink to the structure and size 
of a 2% mixture. To prepare the 3% alginate gel, 3 g of Alginic acid sodium salt from 
brown algae was mixed with 100 mL of 0.9% NaCl. This mixture was spun for 24 hours 
at 650 rpm using a magnetic stir bar and corresponding spinner. The mixture was 
checked periodically during the 24 hours, and in the case of clumping, large pieces were 
broken apart to increase uniformity. After the alginate solution is prepared, it was then 
autoclaved to eliminate chances for contamination. Once completed, 19 mL of alginate 
was mixed with 1 mL of X-gal stock solution (created by mixing 20 mg in 1 mL of 
dimethylformamide) for 4 hours. This ratio of alginate to X-gal was chosen to previously 
obtain a 1:1 ratio of alginate to X-gal to produce uniform results within the alginate gels.
 After optimization, this 1:1 ratio was determined to be non-ideal for our protocol. 53
Therefore, the concentration of X-gal in the alginate was increased. 
 
3.2.4.2 Alginate Capsule Preparation. ​Alginate capsules were prepared by using 1 mL 
of alginate mixed with X-gal. To create the slabs, a 1 mL syringe and an 18 gauge, 1.5 in. 
long needle were used. Using constant and steady pressure application, small and uniform 
capsules were deposited directly into the 1.5% CaCl​2​ cross-linking solution. This method 
of capsules preparation was used to allow for higher optical observations as our team 
optimized our sensor’s functionality. After cross-linking for 30 minutes, the capsules 
were removed from the solution and filtered using a cell strainer. The capsules were 
washed three times with 0.9% NaCl to stop all cross-linking activity.   54
53 Mobed-Miremadi, Maryam. “Alginate Mixing Preparation .” 2 Feb. 2018. 
54 Cheryl Simpliciano, Larissa Clark, Behrokh Asi, Nathan Chu, Maria Mercado, Steven Diaz, Michel Goedert, 




3.2.5 Monitoring Biomolecular Activity on the Sensor 
Biomolecular activity on the sensor is monitored every hour by one of three 
senior design team members. The intensity of the blue color is observed by the human 
eye, and results are recorded by subjective words describing characteristics such as color, 
turbidity, or separation of layers. 
During optimization and confirmation experiments (See 4.22 and 4.23), the 
intensity of the blue color was observed by the human eye referencing the following scale 
derived by assigning arbitrary values to the range of blue intensities produced in the 
experiment. Blue intensity was observed at hourly or bi-hourly time intervals before the 
optimum time for observation and data collection was determined. 
 
 
Figure 4. Original used to assign arbitrary values to blue color on the sensor. ​This scale was originally used to 
attempt to quantify blue color change results. This allowed for the normalization of results before our group was 
able to create an accurate and precise scale according to the actual obtained color change.  
 
and Validation Using Diffusivity Determinations.” ​Journal of Surface Engineered Materials and Advanced 





3.2.6 Measurement of Biomolecular Activity on the Sensor 
After 8 hours, when the optimum blue color change was observed, a picture of 
sensor was taken using an iPhone camera. The image was uploaded to ImageJ, an open 
source image processing program developed at the National Institutes of Health. As seen 
in ​Figure 5, ​mean intensity values of each well in the images were extracted and 
imported into Excel. The intensity values were normalized to the control wells, and 


















Figure 5. ImageJ tool, analysis methods, and results. ​Each well-plate was sampled using the 




CHAPTER 4: RESULTS AND DISCUSSION 
 
4.1 Determination of Optimal ​E. coli​ Strain and Enzyme Combination 
4.1.1 Experiment 
ß-glucuronidase and ß-galactosidase were compared as optimal enzymes to detect 
in BL21 ​E. coli​ in order to produce the most intense blue color. The ​E. coli​ was grown in 
2 mL of LB broth and 200 µL of IPTG, a molecular mimic of allolactose, in order to 
induce the ß-galactosidase. Two serial dilutions were prepared using phosphate buffer to 
obtain concentrations of ​E. coli​ ranging from 3.16 x 10​8​ to 10​4​ CFU/mL. Both dilutions 
were lysed using the B-PER protocol. One dilution used the substrate X-gus to react with 
ß-glucuronidase, and the other dilution used the substrate X-gal to react with 
ß-galactosidase. Lower limits of detection were determined by observing any trace of 
blue color in each centrifuge by eye. 
Another experiment was performed to determine if a natural strain of ​E. coli 
would best fit the model of our desired final product. The cells were grown with 200 µL 
of pasteurized human breast milk (HBM), replacing IPTG, in order to induce production 
of ß-galactosidase. Three serial dilutions were prepared using HBM as the buffer. The 
naturally occuring strain “SCU-104” was inoculated into one dilution ranging from 3.16 
x 10​8​ to 10​3​ CFU/mL. BL21 ​E. coli​ was inoculated into two dilutions ranging from 2.26 x 
10​8​ to 10​3​ CFU/mL. All dilutions were lysed using the B-PER protocol. The SCU-104 
dilution used X-gal, while the BL21 dilutions used X-gal for one and X-gus for the other. 
Binary existence of blue color was determined by eye in each centrifuge tube. 
 
4.1.2 Results 
In the experiment comparing ß-glucuronidase to ß-galactosidase, the 
X-gal/ß-galactosidase detection method proved to be more sensitive at a 1.00 x 10​7 
CFU/mL lower limit of detection after 10 hours, whereas the X-gus/ß-glucuronidase 
yielded a lower limit of 3.16 x 10​8​ CFU/mL in the same period of time. 
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In the experiment comparing the two ​E. coli ​strains, SCU-104 and BL21, no color 
was observed in the BL21 dilution using X-gus after 10 hours. For BL21 using X-gal, a 
1.00 x 10​6​ CFU/mL lower limit of detection was observed after 10 hours. For SCU-104 
using X-gal, a 3.16 x 10​6​ CFU/mL lower limit of detection was observed after 10 hours. 
 
4.1.3 Discussion 
ß-galactosidase was determined to be a more sensitive method of detection than 
ß-glucuronidase. We decided to continue our experiments using ß-galactosidase and 
X-gal for the enzyme-substrate reaction. Although the limit of detection for BL21 was 
slightly lower than that of SCU-104, we decided to use the SCU-104 strain going 
forward, as the naturally occuring strain better represents ​E. coli​ that our device would 
encounter in the real world. The blue intensity for each concentration of ​E. coli​ was also 
more intense in the SCU-104 strain. 
 
4.2 Viability of Alginate Gel Entrapment 
4.2.1 Experiment 
Alginate was prepared in a ratio of 1 mg X-gal:1 mL alginate. 1 mL of alginate 
was dispensed from a syringe onto a glass slide. The alginate was cross linked with 1.5% 
CaCl for 1 hour. Cross linking was stopped with 0.9% NaCl. The alginate was cut into 9 
approximately equal sizes; each piece was placed in a 12 well plate to await dispensing of 
lysate. A serial dilution of SCU-104 ​E. coli​  was prepared in HBM with ranges of 3.16 x 
10​8​ to 10​4​ CFU/mL. The dilution was lysed with the B-PER protocol. Lysate was 
dispensed in 20 µL volumes onto each piece of alginate in the 12 well plate. The time 
between the end of cross linking and the dispensing of lysate was 10 minutes. Color was 
observed by eye in hour increments throughout the day. 
 
4.2.2 Results 
The first noticeable color change appeared in the top concentration, 3.16 x 10​8 





This experiment simply determined that we can observe color change in alginate. 
From here we decided to further explore the possibility of alginate as a medium for our 
enzyme-substrate reaction. 
 
4.3 Effect of Substrate Concentration in Alginate Entrapment 
4.3.1 Experiment 
A serial dilution was created to obtain concentrations ranging from 
3.16 x 10​8​ to 10​4​ CFU/mL. Two separate dilutions were created identical and were tested 
on alginate slabs with different ratios of substrate concentrations entrapped within its 
matrix. One dilution was lysed with the B-PER Protein Extraction Reagent Kit and an 
identical dilution was lysed with the standard Miller Permeabilization. Alginate slabs 
were created in two different ratios: 1:1 X-gal substrate/1 mL of alginate and 2:1 X-gal 
substrate/1 mL of alginate. The prepared slabs were each cut into two rows of eight 
segments. All thirty-two slabs were placed within a 48-well plate and received assay 
samples that underwent both lysis procedures.  
 
4.3.2 Results 
The Miller Permeabilization protocol consistently produced faster results 
compared to the B-PER protocol. For both lysis methods, the 2:1 substrate/alginate 
mixture originally produced a darker color change, however, over time, the difference 




Because both ratios of substrate to alginate produced similar color change after 
the same amount of time, for simplicity, future experiments were conducted using a 1:1 
substrate/alginate mixture. Our team deemed that there was no significant difference 
when using such ratios.  
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4.4 Evaluation of Uniformity of Color Diffusion in Alginate 
4.4.1 Experiment 
Samples of milk were inoculated with 3.16 x 10​8​ CFU/mL, lysed with two 
different lysis protocols, and deposited on alginate (1 mg X-gal/1mL alginate) slabs to 
test for uniformity of the color diffusion throughout the gel upon and after reaction. The 
prepared slabs were cut into two rows of eight segments. The top eight segments were 
placed in individual wells in a 48-well plate and received assay samples that underwent 
Miller permeabilization; the bottom six segments were also placed in individual wells in 
a 48-well plate, but received assay samples that underwent B-PER lysis.  
 
4.4.2 Results 
More intense and uniform color change was observed on slabs which had been 
covered in assay that underwent Miller permeabilization than those that had been covered 
in assay that had been lysed using B-PER. Overall, the segments varied in uniformity and 
diffusion of blue color, and much of the blue color collected on the edges or corners of 
the slab segments. 
 
4.4.3 Discussion 
Because uneven and irregular distribution of blue color change remained an issue, 
the capsule method was explored because it offers more desirable uniformity. 
 
4.5 Verification of Alginate Contamination 
4.5.1 Experiment 
A prepared batch of alginate containing X-gal was stored in a sealed beaker for 
seven days. A second batch of alginate was prepared without X-gal, autoclaved for 







Blue color change was observed in the unsterilized beaker after one week of 
storage. The autoclaved alginate/X-gal mixture remained unchanged after one week of 
storage; no color change was observed. 
 
4.5.3 Discussion 
The blue color change indicated seemingly spontaneous production of the blue 
precipitate 5,5'-dibromo-4,4'-dichloro-indigo. Because ​E. coli​ or ß-galactosidase had not 
been deposited onto or into the prepared alginate, it was unclear what contaminate had 
been hydrolyzed by the X-gal within the prepared alginate and then dimerized and 
oxidized into the blue product. In order to rule out the possibility of spontaneous color 
change without the addition of a ß-galactosidase-expressing contaminate, a sample batch 
of alginate was autoclaved, mixed with X-gal, stored for observation. The stability of this 
mixture over time indicates contamination of the first alginate by some sort of 
contaminate. Sterilization of the alginate mixture prior to the addition of X-gal prevents 
foreign contamination and supports the shelf life of an alginate-based solution. 
 
4.6 Alginate Capsule Method and Effect of Induction 
4.6.1 Experiment 
An experiment was created to verify that the colorimetric reaction is replicable on an 
alginate capsule. 3 mm alginate capsules at a 1:1 substrate/alginate ratio were created 
using the described manufacturing method in ​Section 3.2.4.2​. A single concentration at 
3.16 x 10​8​ CFU/mL and was placed onto the prepared alginate capsules to simply test for 




Color change was obtained in the sample after 24 hours. No color change was 





Our team determined that our assay is replicable on alginate capsules.  
 
4.7 Validation of Alginate Capsule Method 
4.7.1 Experiment 
Previously, alginate capsules were created by mixing the anhydrous form of the 
substrate X-gal with alginate to create a 1:1 substrate/alginate mixture. To validate the 
alginate capsule method and produce more uniform color change through the capsule’s 
surface, our team experimented by mixing 20 mg of X-gal in 1 mL of 
Dimethylformamide (DMF) to create a stock solution. 19 mL of alginate and 1 mL of 
X-gal stock solution were mixed overnight and 3 mm capsules were created using the 
described manufacturing method in ​Section 3.2.4.3​. A serial dilution was created ranging 
from 10​8 ​to 10​2​ CFU/mL and was deposited directly onto the capsules.  
 
4.7.2 Results 
Hourly observations were recorded. Significant color change was observed in the 
top two concentrations: 10​8​ CFU/mL and 10​7​ CFU/mL. 
 
4.7.3 Discussion 
The replicability of our entire assay on various concentrations of ​E. coli​ contaminated 
milk was clear, however our assay clearly had flaws. In the time period that we recorded 
observations, we saw minimal color change. In previous experiments, our team witnessed 
qualitative results in lower concentrations, and in this experiment, we did not observe the 
same robustness of our assay. While we were able to conclude that our assay is replicable 







4.8 Optimization of Induction for Cell Growth 
4.8.1 Experiment 
In effort to optimize the production of our enzyme ß-galactosidase, our team 
optimized our cell growth process to find the ideal milk induction volume. Twelve 
different tubes of cells were incubated with varying milk volumes: 0, 20, 40, 60, 80, and 
100 µL. Six dilutions were created in water and six dilutions were created in milk to 
compare our results from a relevant experiment environment to an ideal experiment. 
Serial dilutions were created by creating samples with various concentration of ​E. coli 
cells ranging from 10​8 ​to 10​2​ CFU/mL. All cells were lysed using the B-PER lysis 
protocol. 100 µL of each sample was deposited into a 96-well plate and observed hourly 
for 8 hours.  
 
4.8.2 Results 
An intense blue color change was observed in top two concentrations in all 
dilutions. Observations were recorded hourly for an 8 hour period and were observed 
again after 24 hours. 
 
4.8.3 Discussion 
While an intense blue color change was observed in all dilutions in the top two 
concentrations at 10​8​ CFU/mL and 10​7​ CFU/mL, the dilution with a milk induction 
volume of 100 µL produced the most intense blue color. Though we optimized the milk 
induction volume, we saw flaws with the results we obtained. In previous experiments, 
we witnessed color change in concentrations much lower than the threshold obtained 
from this experiment, detecting around 10​4 ​CFU/mL in comparison to the observed 10​7 
CFU/mL.  In the time period that we recorded observations, we saw minimal color 
change. In previous experiments, our team witnessed qualitative results in lower 
concentrations, and in this experiment, we did not observe the same robustness of our 
assay. While we were able to conclude that the milk induction was optimized further 
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towards the ideal condition, our experiment also displayed significant flaws in our assay 
design. 
 
4.9 Optimization of Sample Volume for Detection Intensity 
4.9.1 Experiment 
To determine the ideal volume of milk sample necessary to achieve optimum blue 
color change, the sample volume of contaminated milk added to the prepared alginate 
capsules was varied. Serial dilutions were created by creating samples with various 
concentration of ​E. coli ​cells ranging from 10​8 ​to 10​2​ CFU/mL. All cells were lysed using 
the B-PER lysis protocol. 20, 40, 60, 80, and 100 µL of inoculated milk dilutions were 
deposited onto the capsules in a 96 well plate and observed after 8 hours. 
 
4.9.2 Results 
The blue color change increased in intensity as the volume of milk increased; the 
most intense blue color was produced in the wells containing 100 µL.  
 
4.9.3 Discussion 
Although this result reflects the understanding that a more intense blue 
corresponds to a greater volume of contaminant, it also indicates that the minimum 
volume of sample required to produce a reaction observable by the human eye. The most 
intense blue color change with 100 µL informs the protocol for the end user. 100 µL of 
sample enables the alginate capsule to be fully emerged and thus take advantage of all of 
the substrate XG that diffuses out of the capsule—hypothetically radially—and reacts 
with the ß-galactosidase in the milk. 
 
4.10 Optimization Runs (4-level, 5-variable)  
4.10.1 Experiment 
In order to determine which variables had the greatest impact on the reaction 
overall, an L​16​ Taguchi orthogonal array experiment was conducted with a 
52 
 
“larger-the-better” optimization goal.  This factorial design entails a four-level, 55
five-variable array of different combinations of the variables. The formulae needed to 
determine the optimized level of parameters based on the sensitivity (S​m​), signal to noise 
ratios (S/N), difference (D), and rank (R) using larger-the-better-optimization are given in 
Equations 1–4. 
 
where i corresponds to the level, j corresponds to the factor, and L is the total number of levels. 
Rank, ​R​ is given by: 
 
Signal-to-noise ratio (dB) for the jth experiment, (S/N)​j​ is given by: 
 
where ​n​ is the total number of replicates per experiment, and ​Y​mj​ is the measured viability for the 
m​th trial of the ​j​th experiment. For the purpose of our timeline, only one experiment was 
completed using the Taguchi method. 
Sensitivity (dB) for the jth experiment (S​m​)​j​ is given by: 
 
The variables that were analyzed include the volume of milk added to the cell growth 
tubes for induction, the volume of X-gal substrate added to individual capsules, the lysing 
incubation time, the temperature at which the reaction took place, and the concentration of ​E. 
coli​ cells in the milk sample. The volumes of milk added for induction included 0, 50, 100, and 
150 µL. The lysing incubation times included 10, 15, 20, and 25 minutes. The temperatures 
55 Jared Hara, Jordan Tottori, Megan Anders, Smritee Dadhwal, Prashanth Asuri & Maryam Mobed-Miremadi 
(2016) Trehalose effectiveness as a cryoprotectant in 2D and 3D cell cultures of human embryonic kidney cells. 
Artificial Cells, Nanomedicine, and Biotechnology, 45:3, 609-616, DOI: 10.3109/21691401.2016.1167698. 
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included 23, 37, 40, and 45ºC. The concentration of ​E. coli​ cells included 3.16 x 10​5​, 10​6​, 10​7​, 
and 3.16 x 10​7​ CFU/mL. 16 combinations of these five variables were prepared for deposition on 
alginate capsules and observed hourly for 10 hours. 
 
4.10.2 Results 
Two combinations of variables that produced the most intense blue color in the 
shortest amount of time were identified: Combinations G and M. “G” consisted of 50 µL 
milk for induction, 20 minutes of lysing incubation time, 100 µL X-gal, 37ºC reaction 
temperature, and 3.16 x 10​7​ CFU ​E. coli​/mL milk sample. “M” consisted of 150 µL milk 
for induction, 10 minutes of lysing incubation time, 100 µL X-gal, 40ºC reaction 
temperature, and 3.16 x 10​7​ CFU ​E. coli​/mL milk sample. Although another combination 
produced a comparatively dark blue color, it was not identified as a desirable 
combination because it took longer for the color to develop and it required a 45ºC 
reaction temperature, which would require the end user to spend more energy and money 
to maintain a warmer temperature that is less common in conventional laboratory 
settings. ​S/N ​charts can be seen in ​Appendix VII​. 
 
4.10.3 Discussion 
This Taguchi experiment allowed for the optimization of possible combinations 
for the given five variables. To reduce the number of experiments to a practical level and 
obtain the most information, only five variables were tested. From the 16 possible 
combinations, two favorable ones were observed and selected for confirmation runs (​4.11 
Confirmation Runs​). 
Additionally, the most important variables could be identified using the 
Signal-to-Noise ratios of each of the variables. The variables that have the greatest impact 
on the reaction are volume of milk for induction, ​E. coli​ concentration, and temperature 
at which the reaction takes place, whereas the lysing incubation time and substrate X-gal 
concentration have less of an impact on the outcome. We can infer this by looking at the 
absolute value of the S/N ratio for each variable as well as the difference between each 
variable’s highest and lowest S/N ratio value. A higher absolute value determines a 
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variable to be more significant. A greater difference in S/N ratios among different 
conditions for one variable also determines that variable to be more significant in 
producing blue color at a lower limit of detection in a shorter amount of time. 
 
4.11 Confirmation Runs 
4.11.1 Experiment 
Experiment 4.10 was repeated with the two best performing combinations G and 
M. Three replicates of each of the combinations were prepared. Instead of limiting the ​E. 
coli​ concentrations to the four original ones chosen in the previous experiment, full 
dilutions ranging from 10-10​8​ CFU/mL as well as a control with no contamination were 
prepared. These dilutions were prepared for deposition on alginate capsules and observed 
hourly for 10 hours. 
 
4.11.2 Results 
The blue color change was more intense and over the same amount of time in 




This experiment confirmed that the procedure was replicable and clarified that the 
second combination M (150 µL milk for induction, 10 minutes of lysing incubation time, 
100 µL X-gal, 40ºC reaction temperature) produced the most ideal results. This guided 
the current protocol for the use of the sensor. The shorter incubation time reduces overall 
time for detection and the 40ºC reaction temperature is feasible in milk bank and 










4.12 Verification of Optimization on Alginate Capsules  
4.12.1 Experiment  
Experiment 4.11 was repeated with only combination M on alginate capsules. 
B-PER protocol had been employed in experiment ​4.11 Confirmation Runs​ for its 
shorter time and overall ease, but given the superiority of the Miller permeabilization in 
experiments ​4.3 Effect of Substrate Concentration in Alginate Entrapment​ and ​4.4 
Evaluation of Uniformity of Color Diffusion in Alginate ​on alginate slabs. Thus, the 
two lysing procedures were also compared on alginate capsules using the identified 
optimal combination of factors.Full dilutions ranging from 10-10​8​ CFU/mL as well as a 
control with no contamination were prepared. These dilutions were prepared for 
deposition on alginate capsules and observed hourly for 10 hours. Images of the wells 
were taken eight hours after the completion of the the protocol and image analysis was 
performed using ImageJ. 
 
4.12.2 Results 
More intense blue color changed was achieved in eight hours using the B-PER 
protocol as opposed to the Miller protocol. A spectrum key was generated corresponding 




Figure 6. The Quantified Results of Current Prototype Replicates. ​Using our quantified, replicable data, we were 




As the concentration of the ​E. coli​ in the milk increased, so the did the color 
intensity of the captured image of the sensor well. The alginate capsule sensors produce 
the expected result. The negligible standard deviation on the 1 CFU/mL wells indicates 
that the sensor is highly sensitive. The significant separation between standard deviations 
on the lower ​E. coli ​concentrations (10-10​3​ CFU/mL) further supports the sensor’s 
sensitivity. The overlapping standard deviations for the middle ​E. coli​ concentrations, as 
reflected by the similar blue shades of color that are difficult to differentiate via the 
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human eye, indicate the variability introduced by the image capture method. Ambient 
lighting and light refraction through the plastic of adjacent wells in the well plate prevent 
more distinct blue color from being captured. 
 
CHAPTER 5: COSTING ANALYSIS   
 
Overall, the project fell within the budget and is comparable to current industry costs for 
bacterial culturing and screening in Mumbai, India according to research conducted at Sion 
Hospital.  
 
Cost estimates for production using the small-scale materials were derived and are outlined in the 
table below. The complete product includes the gel capsule prototype, which consists of the 
X-gal and alginate, in conjunction with the two lysing protocols. 
 
Table 6. ​The cost estimates for a single use of a complete sensor product.  
 Cost Per Sensor Using Miller 
Protocol ($) 
Cost Per Sensor Using B-PER 
Protocol ($) 
XG 0.0003 0.0003 
Alginate 0.0047 0.0047 
Lysing Protocol 0.0410665 0.31 
 0.046 0.32 
 
Although the Miller protocol makes the complete product dramatically cheaper, both the Miller 
protocol and the B-PER protocol fall under the target cost of $1.00 per sensor. While the Miller 
protocol would make pricing not only competitive but also cheaper than the current practice of 
bacterial culturing, it is not particularly user-friendly and frugal. A lab technician may need 
special training for the careful handling of hazardous chloroform, and it requires a hood. The 




CHAPTER 6: ENGINEERING STANDARDS AND REALISTIC 
CONSTRAINTS 
 
6.1 Ethical Justification: Lack of Research  
Breast milk is known throughout the medical community as the best source of nutrition 
for infants with countless benefits compared to alternatives such as formula. Though a key 
source of factors that can aid in development and growth, like the previous team, our team 
encountered an astounding lack of research surrounding breast milk diagnostics and related 
banking systems. To further the dedication that last years’ team made to narrowing the 
knowledge gap, our team also devoted ourselves to enhance the scientific knowledge 
surrounding breast milk. 
 
6.2 Importance of Ethics for MilkGuard 
Our team dedicated ourselves to creating a technology that was both scientifically and 
ethically sound to produce the most accurate, safe, and applicable device to the unmet medical 
need. The project surrounds an industry that caters directly to those affected by the greatest 
risk--infants. Below are ethical considerations regarding team organization, product design, and 
cultural and social ethics: 
 
Table 7. ​Team Organization to Uphold Project Ethics 
Ethical Consideration Established Practice 
Team Member Ethics Established Weekly Meetings 
Weekly meetings were established to ensure that all team 
members were kept accountable and up to speed with the 
project. Each meeting was documented with an agenda and 
thorough minutes taken on a rotating schedule.  
 
Lab Etiquette 
Team members worked to establish lab times that were 
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consistent for a majority of or all team members. This 
allowed for thorough collaboration and effective, equal use of 
lab time.  
Team Member Contributions Collaborative Environment 
All team members were encouraged to share opinions, ideas, 
and creativity with the team. While team members may have 
differing opinions, the group was dedicated to staying 
open-minded and considering all possible perspectives of the 
team.  
 
Delegation of Tasks 
Team members divided certain tasks and became Subject 
Matter Experts (SME) in specific areas of the project. 
Whether taking charge of communication with a specific 
partnership or leading a step during lab time, each member 
was tasked to staying up to date with the specific subject area.  
Ethical Partnership Building 
and Management 
Contact with Advisors and Collaborators 
The team met with highly involved advisors at least once a 
week to maintain positive trajectory towards team goals. 
Collaborators and partnerships were contacted periodically to 
maintain relationship and provide necessary updates. 
 
Establishment of New Contacts 
The team traveled to the Bay Area Global Health Innovation 
Conference on May 4 - 5. Here, the team interacted with 
organizations and professionals in the global health sector to 
establish greater connections and collaborations within the 
field. 
 
Partnership with Engineering World Health (EWH) 
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The team worked closely with the Engineering World Health 
students to maintain a positive and efficient relationship. 
Clear goals and tasks were assigned to team members to 
ensure that both parties were equally as invested in the 
project’s impact. 
 
The National Society of Professional Engineers’ Code of Ethics for Engineers  and the World 56
Health Organization’s (WHO) Guide for Open Point-of-Care Diagnostic Platforms for Low to 
Middle Income Countries  were consulted to ensure that our design met criteria applicable in 57
our target setting. 
 
Table 8. ​Product Design Ethics 
Ethical Consideration Established Practice 
Result Reporting and 
Experiment Reproducibility 
Lab Notebooks and Related Electronic Documents 
Each member was required to record results physically in lab 
notebooks and results and experiment design were transferred 
into an electronic log of experimentation. Results and 
experiments were overseen by Dr. Craig Stephens, Dr. Ashley 
Kim, and Dr. Maryam Mobed-Miremadi as acting advisors, 
professionals, and collaborators on the project. 
 
Experiment Reproducibility  
Experiments were conducted in sets of three replications to 
confirm results and experimental design. Results were 
quantified using ImageJ and standard deviations were 
calculated to analyze result deviations from the norm.  
56 Nspe.org. (2018). ​Code of Ethics | National Society of Professional Engineers​. [online] Available at: 
https://www.nspe.org/resources/ethics/code-ethics [Accessed 14 Jun. 2018]. 
57Who.int. (2018). [online] Available at: http://www.who.int/phi/Open_DX_Platform_WHO_Call_for_Interest.pdf 
[Accessed 14 Jun. 2018]. 
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Breast Milk Handling  Donor Confidentiality 
Breast milk samples were obtained through the Human Milk 
Banking Association of North America (HMBANA) through 
a research application. Raw and pasteurized milk was 
requested without donor information such as demographics 
and key identifiers. Sample labels were kept confidential to 
allow for blind experimentation free of biases.  
 
Mother’s Milk Bank of San Jose Partnership 
The team visited Mother’s Milk Bank of San Jose to build 
and maintain a relationship with the director. Per request, the 
team obtained sensitive information and agreed to keep it 




Breast milk treated as a hazardous material in lab and 
followed all applicable waste handling protocols. 
 
Table 9. ​Cultural and Social Ethics 
Ethical Consideration Established Practice 
End User  World Health Organization/Engineering World Health 
In an effort to meet parameters established by the World Health 
Organization and Engineering World Health, costs were kept 
low, user-friendliness was improved, and sensor robustness was 
improved. Doing so will allow it to be more economic and will 
open up distribution to allow for greater access in low-resource, 
vulnerable areas.  
Global Health Awareness Partnerships 
The team worked directly with PATH. This organization works 
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to establish milk banks in low resource settings, so they acted 




Two team members traveled to Sion Hospital in Mumbai, India. 
By traveling to a low-resource setting where breast milk banks 
are prevalent, greater design constraints and criteria were 
developed to further the applicability of the project. 
Maternity  Breastfeeding Culture 
The goal of the project is to promote breastfeeding and breast 
milk donation so that all infants may have access to such 
nutritional content.  
 
Maternal Integrity 
In effort to promote breastfeeding, our team considered the 
ethical ramifications of informing mothers of their milk’s 
nutritional content and potential contamination. Our goal is not 
to dissuade mothers from breastfeeding or breast milk donation, 
so we collaborated with PATH to maintain the ethical integrity 
of the project’s result documentation and communication. 
 
6.2.1 Potential Risk Modes and Analysis 
To address potential failure risks that may result from our product, a Failure 
Modes Effects and Analysis was conducted to identify key factors that may result in the 
failure in the device and the related severity of such failure. The following were 
identified as the greatest sources of failure risk: 
● Milk Volume Added 
● Cross-Contamination 
● Device Reuse 
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● Lack of Access to Higher Temperatures 
While not all of these failure risks were completely addressed by the team, next steps 
were explored in order to address such risks. 
 
6.2.1.1 Potential Failure Modes and Analysis: Milk Volume Added. ​While this 
variable is key to the experimental design ​in vivo​, it is not as applicable within a clinical 
lab setting. In industry, samples are composed entirely of breast milk and related factors, 
and small milk volume additions are not applicable in a greater testing facility. This 
factor is key to experimental design but is not applicable in an industry setting. 
 
6.2.1.2 Potential Failure Modes and Analysis: Cross-Contamination. 
Cross-contamination is a crucial failure mode of our device. Currently, the 
specificity of our bacterial contamination is unknown. Because our device relies on an 
enzyme-substrate reaction specifically for ​E. coli ​bacteria with an intact LacZ operon and 
our team specifically inoculated our milk samples with known concentrations of bacteria, 
we know that our device is applicable with such related bacteria. However, our device is 
currently not applicable to other species of bacteria that do not rely on such 
enzyme-substrate reaction.  
Our team confirmed that substrate entrapped within a cross-linked alginate matrix 
allowed for molecules to retain their bioactivity to allow for the enzyme-substrate 
reaction to take place. Since this method was verified, we anticipate that this mechanism 
is applicable on a greater scale to other related contaminants. For future work, individual 
alginate capsules can be manufactured with specific enzymes entrapped in them. These 
capsules will then act like chambers on the sensor to be able to detect multiple areas of 
contamination, thus, allowing for a more specificity and reduction of false results due to 
cross-contamination. 
 
6.2.1.3 Potential Failure Modes and Analysis: Device Reuse. ​Our device functions as a 
single-use product. Originally having an opaque coloration, the device changes to a 
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permanent, stark blue. This color change is irreversible, so it does not allow for the reuse 
of the MilkGuard product. Because of this stark color change, we anticipate that users 
will know that our device are single-use products.  
 
6.2.1.4 Potential Failure Modes and Analysis: Lack of Access to Higher 
Temperatures. ​Our device produces optimal results at 8 hours given that the reaction is 
allowed to take place at 40°C. Our team is aware that not all laboratories have access to 
electricity and power to allow for certain equipment to function indefinitely. Therefore, 
our team explored other potential biomaterials that will reduce the need for such higher 
temperatures. We are aware that there are biomaterials that retain a greater potential 
energy, which reduces the need for consistent access to these higher temperatures.  
 
6.3 Engineering Standards for Consideration 
According to the National Society of Professional Engineers’ Code of Ethics for 
Engineers, professional engineers must take into consideration the impact of our design in the 
areas of ethics, science, technology and society, civic engagement, economic, health and safety, 
manufacturability, usability, sustainability, and the environmental impact. Such considerations 
must be considered to ensure that the technology not only benefits the consumer, but also 
prevents negative impact on the surrounding community. The following delineates MilkGuard’s 
potential impact in a selection of these areas. 
 
6.3.1 Ethical Considerations 
When meeting with breast milk banking experts and maternal and infant health 
experts, they highlighted the importance of supporting and praising mothers for their 
breast milk. They clearly explained that the results of the testing and diagnostic device 
should not make a mother feel inadequate or deficient in either her breast milk expression 
or the nutritional quality of her milk. There is an obvious ethical obligation that our team 
has to not demean or devalue mothers whose milk is not as nutritious as anothers. 
MilkGuard is not a device that should cause harm or worry for mothers. Instead, it is 
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designed as a tool to improve testing capabilities of breast milk in order to detect for 
bacterial contamination. While the origin of contamination may come from a variety of 
sources, the most important factor is the device will ensure that the breast milk delivered 
to at risk infants. As the project continues, it is crucial that ethical obligations are upheld 
so that mother and infant are encouraged to consistently donate safe breast milk. 
 
6.3.2 Social Impact 
Though breast milk banking is prevalent in some countries, like India and Brazil, 
it is extremely uncommon within the United States. MilkGuard’s research will fill a 
knowledge gap surrounding this industry, and can increase awareness and accessibility of 
these breast milk banks worldwide. With greater and more developed research and 
technology within this sector of maternal health, woman can be empowered to further 
support breastfeeding and breast milk donation. 
 
6.3.3 Health and Safety  
MilkGuard is an extremely simple and easy-to-use diagnostic device that will be 
used primarily by lab technicians with sufficient training in lab settings. Currently, it is 
not ​meant to be used by any mothers or related consumers. It is not meant to be ingested, 
nor is it toxic to human touch. The biomaterials used are bioinert, so it will not cause any 
reaction when in contact with human tissue. In addition, all biomolecules used are used in 
small trace amounts when constructing the device, and these do not pose an immediate or 
severe health and safety risks to the end-user. 
 
6.3.4 Regulatory Requirements  58
According to the Food and Drug Administration, non-invasive diagnostics can be 
considered Class I Devices. Class I devices can be defined as simple devices that pose 
low potential for harm on the end-user. In an effort to better understand the regulatory 
58Fda.gov. (2018). ​Class I / II Exemptions​. [online] Available at: 
https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/Overview/ClassifyYourDevice/ucm051549.ht
m [Accessed 14 Jun. 2018]. 
66 
 
space, our team consulted John Petrovich, CEO of the Alfred Mann Foundation, at the 
Bay Area Global Health Innovation Challenge. His feedback reinforced our assumption 
that MilkGuard would be considered a Class I device if our team decided to pursue FDA 
approval. Though there are FDA and ISO standards that must be met for medical devices, 
because our product is considered a Class I device and is completely non-invasive, it does 
not need to go through certain forms of testing, like biocompatibility or toxicity testing.  
 
6.3.5 Economic Considerations  
MilkGuard is designed to be deployed in low to middle income countries, 
therefore it was designed to be as low-cost as possible. While originally developed on a 
paper-based platform to reduce costs, our team transitioned to a polymer-based platform 
because an inexpensive, organic biomaterial was selected and exceptionally reduced the 
complexity of the sensor. The following is a cost-breakdown of the unit price of a single 
sensor: 
 
Table 10.​ Cost-breakdown of a Single Sensor 








 6.3.6 Manufacturability 
In a previous design, the sensor was constructed with three bands, each with 
several layers deposited. Additionally, it utilized a lateral flow method in order to allow 
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the desired enzyme to travel through the porous filter paper. Since transitioning from the 
silica sol-gel entrapment mechanism to an alginate capsule entrapment method, the 
manufacturability of this device increased exponentially. Once mixed with the X-gal 
substrate, the alginate capsules can be manufactured uniformly utilizing a syringe pump 
which allows for the process to be extremely high-throughput. Such process will allow 
for the rapid and uniform production of the desired alginate capsules which can then be 
easily deposited directly onto the device’s platform before use. 
 
6.3.7 Usability 
The design currently requires that trained lab technicians conduct the testing. To 
be a true point-of-care device in a low to middle income setting according the World 
Health Organization, the device must be extremely user-friendly. Though the device does 
require that the milk samples be pre-treated prior to deposition on the device, the sensor 
is extremely simple and can be easily used even in low-resource settings where 
professionals may not experience the same training modules as their counterparts in high 
income settings.  
 
6.3.8 Environmental Impact 
MilkGuard is a single-use sensor that is easily disposable without complex or 
extensive hazardous waste protocols. Because this design iteration transitioned to a 
alginate-based platform, the environmental impact of our device has decreased. Alginate 
is an organic biopolymer that is a derivative of algae, so it is easily disposed of. In 
addition, little amounts of reagents are used within the sensor, so as a whole, it does not 








CHAPTER 7: SUMMARY AND CONCLUSION  
 
7.1 Project Summary 
MilkGuard began as a project to streamline the testing required within the breast milk 
banking system. It was centered around advocating for greater maternal health technologies and 
increased awareness of the importance of breast milk across the globe. When the project was first 
passed down to our team, it had a limit of detection of 10​5 ​CFU/mL and utilized a more complex 
design. Since then, our team made numerous iterations to the design to meet goals originally 
created at the beginning of the project’s duration. By utilizing a different enzyme-substrate 
reaction for the detection of ß-galactosidase to measure the concentration of ​E. coli ​bacteria, we 
anticipate that the sensor’s mechanism can now be applied to other bacterial contaminants. In 
addition, our team identified and optimized the use of an alginate biomaterial, which allowed for 
a drastic simplification in the sensors design and manufacturability. Lastly, our team optimized 
the conditions at which we conducted our experiments to find the conditions that results in the 
greatest signal. The combination of a different detection method, new biomaterial, and optimized 
conditions allowed for the sensitivity of our sensor to increase to 10 CFU/mL.  
Additionally, to further the project’s goal of increasing awareness about the importance 
of breastfeeding and breast milk donation, our team worked to capture new audiences with our 
project’s impact. In May, our team participated and presented in the Bay Area Global Health 
Innovation Challenge where we networked with established global health organizations and 
professionals. In addition, our team maintained relationships with organizations like PATH and 
EWH to ensure that our message impacted those currently in related industries, and we 
established new contacts with other related organizations, like D-REV, a non-profit organization 
focused on distributing world-class affordable technologies to those in need, to help further the 







7.2 Future Work 
7.2.1 Shelf Life Assessment 
The shelf life of the X-gal substrate lyophilized in the alginate gel needs to be 
assessed in order to figure out how long the substrate will remain effective for use in a 
reaction with ß-galactosidase. 
 
7.2.2 Image Capturing 
Currently, iPhone cameras are used in conjunction with ImageJ to analyze the 
blue color intensity in the alginate gel and solution. A standardized, high quality method 
of image capturing and analysis needs to be implemented in order to ensure the 
confidence of our device’s lowest limit of detection. Further methods could include the 
use of high quality cameras, lights, and microscopes for efficient image capture. 
 
7.2.3 Diffusion Characterization 
We would like to mathematically characterize the diffusion of X-gal out of 
alginate when in contact with a solution containing ß-galactosidase. This research would 
allow us to determine aspects that significantly affect the diffusion rate so that we can 
optimize the sensor’s design to work around such constraints. This characterization will 
help improve the sensor’s efficiency and effectiveness.  
 
7.2.4 Detecting Multiple Contaminants 
Ideally, our device would be able to detect all of the common contaminants in 
breast milk banks. The most common contaminant is ​Bacillus cereus​. Our device would 
need to be able to detect ​Bacillus cereus​ at a high sensitivity in order to be used in breast 
milk banks. ​Staphylococcus​ is another top concern at milk banks in which we hope to be 






7.2.5 Field Testing 
We would like to connect with multiple banks in varying geographical areas and 
resource settings to understand exactly how our device would fit into their respective 
milk banking systems. 
 
7.3 Lessons Learned 
The project provided an educational experience through which we developed the ability 
to design, plan, and execute experiments. In the face of ambiguity or contradicting results from 
multiple experimented, we learned to identify and troubleshoot different variables to adjust and 
test in subsequent experiments. This process strengthened our perseverance and persistence. 
Our challenges largely stemmed from our overall lack of experience in a research 
laboratory setting. Because we came from pre-medicine and medical device tracks, we were less 
familiar with the bioengineering labs and the handling and storage of materials in the labs. A 
significant portion of the fall quarter was spent developing skills and familiarizing ourselves with 
the protocol established by the previous year’s team. In doing so, we faced difficulty printing the 
multiple layers of the sensor using the inkjet printer and the volumetric dispenser. The printer 
was not designed to print more viscous fluids like the polyvinylamine, and the volumetric 
dispenser was considerably time-consuming.  
This challenge hindered efficient manufacturability, ultimately influencing us to explore 
alternative methods of entrapment and sensor construction. Later, we ran into a problem with the 
performance of our assay, which we attribute to the somewhat unpredictable and adaptable 
nature of cell behavior. The same blue intensity was not achieved in low concentrations of ​E. coli 
dilutions using the same cell line that we had been using. This led us to eliminate the possibility 
of contamination, re-plate the cells, and conduct the optimization experiment, which produced 
particularly valuable feedback. 
Our latest challenge involved our method of image capture. We opted to start with an 
iPhone camera for sake of ease, time, and availability as each of our three team members own 
one. However, iPhone cameras are programmed to automatically adjust exposure settings, thus 
preventing consistency across data collection at different time periods by different team members 
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using different iPhones. Additionally, the sensors were located in a plastic well plate in which 
adjacent wells contained different dilutions of contaminant. Ambient lighting throughout the 
plate as well as light refraction from sensors in adjacent wells interfered with the intensity values 
captured by the camera.  
Finally, we shared a lot of the same strengths as a team. But, we struggled to reconcile 
some of our differences. Sometimes, we opted to forego preparatory critical thinking and trust 
that running an experiment would yield informative results. Other times, an analytical thought or 
perspective postponed an experiment in effort to critically evaluate the purpose and design of an 
anticipated experiment. Eventually, we struck a balance between this critical thinking and 
acceptance with ambiguity before moving forward with our experiments. 
We also connected with professionals across a variety of departments (i.e. Public Health, 
Biology, Physics, and Bioengineering). We effectively leveraged their expertise and synthesized 
their input throughout our experimental protocol and innovation design. When confronted with 
little or slow progress, we did not limit ourselves to narrow or obvious ideas. In fact, our 
exploration of alternative approaches led to our new entrapment and production method 
altogether. These strengths were all brought about in our hard work throughout the year. 
Ultimately, this discipline enabled us to passionately communicate our work and vision. And, it 
enabled the dramatic simplification of the sensor’s design as well as expanded manufacturing 
feasibility and scalability. 
Simultaneously, we recognize that we need to further reduce the limit of detection 
(LOD), improve the color change intensity, extend shelf life and storage viability, expand the 
sensor to detect additional contaminants, enhance specificity, and further develop the image 
capture method. 
Overall, we encourage future teams to remain open to new approaches, diversify a team’s 
specialties and strengths, dedicate significant time and patience to learning proper and efficient 
lab skills and protocol, and work with the Engineering World Health team to quantify the social 
impact of a market-ready product. Finally, an effective team will embrace frequent, clear, and 
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APPENDIX I: COMPLETE MATERIALS LIST AND BUDGET 
 
The original budget was $1,855.05 dollars for materials. The Santa Clara School of Engineering 
grant and Engineering World Health grants provided us with $1,500 and $1,000 respectively. 
 
Table 11. ​Complete Budget and Materials List. 
 
Item Use Source Price ($) 
Human breast milk Sample 
Mother’s Milk Bank (San Jose, 
CA) 800 
BL21 Escherichia 
coli cells Detection pathogen 
Dr. Jonathan Zhang, Santa Clara 
University (Santa Clara, CA) 0 
LB Broth Bacterial growth medium 
Sigma Aldrich (St. Louis, MI), 
purchased by previous team 0 
B-PER Direct 
Bacterial Protein 
Extraction Kit E. coli cell lysis 
Thermo Fisher Scientific 
(Waltham, MA) 221 
Whatman 
qualitative filter 
paper, Grade 1 Detection platform 
Sigma Aldrich (St. Louis, MI), 




Polymer activates paper; 
provides adhesive support for 






Substrate for E. coli enzyme 
β- glucuronidase (GUS) 
Sigma Aldrich (St. Louis, MI), 




Substrate for E. coli enzyme 
ß-galactosidase 
Thermo Fisher Scientific 






solution (SS) Sol-Gel precursor 





Used with anhydrous glycerol 
to synthesize Diglyceryl 
Silane (DNS) (Sol-Gel 
precursor) 
Sigma Aldrich (St. Louis, MI), 
purchased by previous team 0 
Dowex 50WX8 
hydrogen form 
Cation exchange resin 
replaces Na+ with H+ in SS 
sol preparation Sigma Aldrich (St. Louis, MI) 88 
Anhydrous glycerol 
Used with TEOS to 
synthesize DNS; 30% added 
to solutions to adjust 
viscosity/surface tension for 
ink-jet printing 
Sigma Aldrich (St. Louis, MI), 
purchased by previous team 0 
Iron chloride Oxidizing reagent 
Sigma Aldrich (St. Louis, MI), 
purchased by previous team 0 
Methytrimethoxysil
ane (MTMS) 
Component of the 
hydrophobic barrier: 
Methylsilsequioxane (MSQ) Sigma Aldrich (St. Louis, MI) 36.3 
Ethanol (EtOH) MSQ synthesis 
Bioengineering Department, 
Santa Clara University (Santa 
Clara, CA) 0 
Hydrochloric Acid 
(HCl) MSQ synthesis 
Bioengineering Department, 
Santa Clara University (Santa 
Clara, CA) 0 
Buchner Funnel SS-gel synthesis 
Chemistry Department, Santa 





0.45-μm SS-gel synthesis 
EMD Millipore (Hayward, CA), 
purchased by previous team 0 
Syringe, 5 ml SS-gel synthesis 
Bioengineering Department, 
Santa Clara University 0 
E. coli Antibody 
(20- ER13) 
Conjugated to magnetic beads 
for E. coli preconcentration 
Fitzgerald (Acton, MA), 
purchased by previous team 0 
Hydrazide-Modifie
d Magnetic Beads 
Conjugated to E. coli 
antibodies for E. coli 




Storage buffer for MB-Ab 
coupling 
Bioengineering Department, 
Santa Clara University (Santa 
Clara, CA) 0 
Epson Stylus C88 
Inkjet Printer 
Improve manufacturability of 
layering molecules 
Best Buy (Richfield, Minnesota), 
purchased by previous team 0 
Ink cartridges 
Improve manufacturability of 
layering molecules 
Amazon (Seattle, WA), 
purchased by previous team 0 
Chloroform 




Santa Clara University (Santa 









Santa Clara University (Santa 
Clara, CA) 0 
Lysozyme 
Used in lysing process in 
tangent with B-PER 
Thermo Fisher Scientific 
(Waltham, MA) 50 
DNAse 
Used in lysing process in 
tangent with B-PER 
Thermo Fisher Scientific 






Positive control for X-gal - 
ß-gal reaction Sigma Aldrich (St. Louis, MI) 81 
Alginate powder 
Used with 0.9% NaCl 
solution to make alginate 
hydrogel 
Bioengineering Department, 
Santa Clara University (Santa 
Clara, CA) 0 
1.5% CaCl solution 
Used to crosslink alginate 
hydrogel 
Bioengineering Department, 
Santa Clara University (Santa 
Clara, CA) 0 
0.9% NaCl solution 
Used with alginate powder to 
make alginate hydrogel. 
Also used to stop crosslinking 
of alginate. 
Bioengineering Department, 
Santa Clara University (Santa 
Clara, CA) 0 
1 mL syringe 
Used to make alginate 
capsules 
Bioengineering Department, 
Santa Clara University (Santa 
Clara, CA) 0 
18G 1 ½ inch 
precision needle 
Used with with 1 mL syringe 
to make alginate capsules 
Bioengineering Department, 
Santa Clara University (Santa 
Clara, CA) 0 
Cell strainer 
Used to filter alginate 
capsules out of CaCl solution 
Bioengineering Department, 
Santa Clara University (Santa 
Clara, CA) 0 








































Statement           
Familiarize with 2016-17 
Team's Experimental 
Protocols and 
Instrumentation           
Take Inventory and 
Order Materials           
Field Research at Milk 
Banks           
Understand Customer 
Needs and Establish 
Criteria           
Review of Literature and 
Exploration of 
Alternative Solutions           
State Project Goal and 
Objectives           
Submit Proposal for 
Undergraduate Programs 
Funding           
Replicate Previous 
Team's Assay in Water 
Buffer           
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Iteration           
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Introduction           
Conduct Assay in 
Donated HBM           
Simulate Sensor in Well 
Assay           
Optimize Lysing 
Procedures           
Print Sensor Layers 
Using HP Volumetric 
Dispenser           
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Test Feasibility of 
Alginate Entrapment           
Apply to Bay Area 
Global Innovation 
Challenge           
Run Experiments to 
Optimize Detection           
Optimize 
Enzyme-Substrate 
Reaction in Alginate 
Slab and Capsules           
Prepare for BAGHIC and 
Senior Design           
Run Final Experiments 
with Improved Image 
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Figure 7. Gantt chart timeline and project deadline goals. ​This Gantt chart helped our team map out our project 
goals for the year and established strict deadlines for us to meet. These deadlines allowed our team to act efficiently 




Figure 8. Design process timeline. ​MilkGuard’s design process timeline helped us establish realistic goals in lab 







APPENDIX III: ß-GALACTOSIDASE AND X-GAL REACTION 
 
 
Figure 9. X-gal/ß-galactosidase reaction. ​When reacting with ß-gal, the X-gal will cleave and hydrolyze. The 








Silica Sol-Gels can entrap and immobilize biomolecules on paper platforms. Silica’s lattice 
structure stabilizes biomolecules without affecting their physical properties or chemical 
structure. These gels can also be loaded into inkjet printers and easily and rapidly deposited onto 
paper without altering its chemical structure.  59
Preparation and Construction of Silica-Sol Gel Sensor 
To prepare the silica sol-gel, 10 mL of ddH​2​0 were mixed with 2.9 g of sodium silicate 
solution to obtain a pH of 13. 5 g of Dowex cation exchange resin were added to the mixture to 
replace Na​+​ with H​+​. The mixture was stirred for 30 seconds to reach a final pH of 4. The gel was 
59 S. M. Zakir Hossain, Roger E. Luckham, Anne Marie Smith, Julie M. Lebert, Lauren M. Davies, Robert H. 
Pelton, Carlos D. M. Filipe, and John D. Brennan. Development of a Bioactive Paper Sensor for Detection of 
Neurotoxins Using Piezoelectric Inkjet Printing of Sol−Gel-Derived Bioinks. Analytical Chemistry 2009 81 (13), 
5474-5483. DOI: 10.1021/ac900660p 
84 
 
vacuum-filtered through a Buchner funnel. That filtrate was filtered the filtrate through a 
0.45-um membrane syringe filter.  To prepare the X-gal stock solution, 20 mg of X-gal was 60
dissolved in 1 mL dimethylformamide. The polyvinylamine (PVAm) was used in its pure form. 
To prepare the sensor, each of the layers were sequentially pipetted onto the paper within 
a well plate such that the entire surface of the well was coated in the fluid. The layers were 
deposited in the following order: 20 µl PVAm, 20 µl silica sol-gel, 5 µl X-gal, 20 µl silica 
sol-gel. The completed construction was set out to dry for at least 20 minutes before application 
of the lysate. 
 
Alginate Slab Preparation 
Alginate slabs were prepared by depositing 1.5 mL of alginate mixed with X-gal onto a 
polylysine coated slide and maneuvered in order to create a slab-like geometric shape. Through 
several experiments, our team concluded that a wet-slab method was ideal for our application. 
Following this method, once the initial slab was created, it was immediately cross-linked in 1.5% 
CaCl​2​ for approximately 1 hour. This divalent cross-linker was chosen to create a uniform pore 
size of approximately 3 nm, which is ideal for our application based upon the size of our enzyme 
(ß-Galactosidase) and substrate (X-gal). Once cross-linking was completed, the slab was were 
washed three times with 0.9% NaCl to stop all cross-linking activity and allowed to dry for 20 









60  S. M. Zakir Hossain, Roger E. Luckham, Anne Marie Smith, Julie M. Lebert, Lauren M. Davies, Robert H. 
Pelton, Carlos D. M. Filipe, and John D. Brennan. Development of a Bioactive Paper Sensor for Detection of 
Neurotoxins Using Piezoelectric Inkjet Printing of Sol−Gel-Derived Bioinks. Analytical Chemistry 2009 81 (13), 
5474-5483 DOI: 10.1021/ac900660p 
61 Y. Nakashima, K. Tsusu, K. Minami, Y. Nakanishi. “Development of a cell culture surface conversion technique 





APPENDIX V: MILKGUARD INITIAL DESIGN 
 The initial design of the sensor contains three separate regions each with multiple layers 





Figure 10. Initial sensor design and region breakdown. ​The schematic of the layers that entrap the biomolecule 
and makeup the sensor.  The original sensor design is composed of three bands with various layers in each. (​a) 62
displays the general concept of original sensor design, and ​(b) ​breaks down each band into the number of layers 
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Table 12. ​Breakdown of each band deposited on the sensor and its corresponding layers.  
Region Layers 
Region I Layer 1: 0.5% poly(vinyl amine) 
Layer 2: Silica sol-gel 
Layer 3: FeCl​3 
Layer 4: Silica sol-gel 
Region II Layer 1: 0.5% poly(vinyl amine) 
Layer 2: Silica sol-gel 
Layer 3: X-Gus 
Layer 4: Silica sol-gel 
Region III MSQ  
 
0.5% poly(vinyl amine) (PVAM). ​The initial design utilized a thin coating of 0.5% of 
PVAM at the base of Region I and Region II. This thin layer was used in order to 
create a barrier between the silica sol-gel and the paper platform. Such a layer was 
there in order to prevent the silica sol-gel from leaching into the paper platform to 
preserve the integrity of the sensor itself. 
 
Silica Sol-gel. ​As discussed in previous sections, the silica sol-gel layer was used to 
entrap biomolecules and preserving such bioactivity. 
 
Ferric Chloride (FeCl​3​). ​Ferric chloride acted as an oxidizing agent in order to 
catalyze the reaction to produce a blue color change at a faster rate.  
 
X-Gus. ​Previously, a nonpathogenic strain of ​E.coli ​(BL.21) was chosen as the cell 
line in the experimental procedure with the idea that once the sensor was optimized, its 
functionality could be applied to other contaminants. BL.21 have a specific enzyme 
87 
 
ß-glucuronidase (GUS) that upon its reaction with the substrate 
5-bromo-4-chloro-ß-D-glucuronide sodium salt (X-Gus), produces a blue color 
indication.   63
 
Methylsilsequioxane (MSQ). ​MSQ was used as a hydrophobic barrier in order to stop 
the lateral flow of the sample. This concentrated the blue color change in Region II to 
ensure for accurate readings that could be correlated to quantitative results.  
 
APPENDIX VI: MILLER PROTOCOL  
 
Instead of “lysing” the cell membranes, the Miller protocol permeabilizes the ​E. coli​ cells by 
widening the pores of the membrane. The widening of the pores allow for ß-galactosidase to exit 
the cell and furthermore mix with X-gal. The cells are permeabilized by adding 100 µl 
chloroform and 50 µl 0.1% sodium dodecyl sulfate (SDS).  64
 
APPENDIX VII: SIGNAL TO NOISE RATIOS 
 
Our group compared signal to noise ratios of the five variables we selected as the most 
significant in the experimentation. Such values can be seen in ​Figure 11 ​and were used to 
establish which of the five variables created the best signal. 
63  Morrison, Nina; O’Connor, Samantha; and Weber, Callie, "MilkGuard: Low Cost Paper Sensor for the Detection 
of Escherichia coli in Donated Human Breast Milk" (2017). Bioengineering Senior Theses. 13. 
 






Figure 11. Signal to noise ratios. ​The signal to noise ratios for the following variables were analyzed to determine 
which produced the most significant signal in experimentation.  
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